Psyllid ID: psy9686
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 769 | ||||||
| 260447050 | 590 | lysozyme precursor [Tribolium castaneum] | 0.191 | 0.249 | 0.448 | 9e-26 | |
| 195127299 | 1195 | GI13315 [Drosophila mojavensis] gi|19391 | 0.193 | 0.124 | 0.417 | 1e-25 | |
| 270004918 | 148 | hypothetical protein TcasGA2_TC010351 [T | 0.171 | 0.891 | 0.485 | 1e-25 | |
| 195325805 | 1056 | GM24992 [Drosophila sechellia] gi|194118 | 0.159 | 0.116 | 0.456 | 2e-25 | |
| 256861417 | 590 | lysozyme [Tribolium castaneum] | 0.191 | 0.249 | 0.441 | 2e-25 | |
| 256861419 | 590 | lysozyme [Tribolium castaneum] | 0.176 | 0.230 | 0.479 | 2e-25 | |
| 195492651 | 967 | GE20392 [Drosophila yakuba] gi|194180184 | 0.231 | 0.184 | 0.370 | 7e-25 | |
| 194749625 | 1337 | GF24155 [Drosophila ananassae] gi|190624 | 0.153 | 0.088 | 0.453 | 1e-24 | |
| 195376757 | 1101 | GJ12084 [Drosophila virilis] gi|19415431 | 0.156 | 0.108 | 0.450 | 1e-24 | |
| 195588547 | 868 | GD13037 [Drosophila simulans] gi|1941960 | 0.159 | 0.141 | 0.448 | 2e-24 |
| >gi|260447050|ref|NP_001159495.1| lysozyme precursor [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 125 bits (314), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 69/154 (44%), Positives = 92/154 (59%), Gaps = 7/154 (4%)
Query: 252 SAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKE 311
S +P++ L++L + QIE K F CELAK L + I + TW+CIA E
Sbjct: 296 SKSKMNPLSKLLVLLFVSLCVSLQIEAKVFKRCELAKELKNKHHIPGNQLATWMCIANYE 355
Query: 312 SNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVV 371
S N+ A + K G DHG+FQI+ YWC+ S GK C+AKCS F +N+I DDVACV
Sbjct: 356 SGFNTAAINKKTG----DHGLFQISQIYWCSNSNKPGKACNAKCSDFRNNDIKDDVACVK 411
Query: 372 KIHSQTQRARGNGFQAWSTY-HYC--NTNSKVST 402
KI+++ Q+ GNGF AW Y YC N N+ +ST
Sbjct: 412 KIYNEHQKLSGNGFNAWVAYKKYCRGNNNNNLST 445
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195127299|ref|XP_002008106.1| GI13315 [Drosophila mojavensis] gi|193919715|gb|EDW18582.1| GI13315 [Drosophila mojavensis] | Back alignment and taxonomy information |
|---|
| >gi|270004918|gb|EFA01366.1| hypothetical protein TcasGA2_TC010351 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|195325805|ref|XP_002029621.1| GM24992 [Drosophila sechellia] gi|194118564|gb|EDW40607.1| GM24992 [Drosophila sechellia] | Back alignment and taxonomy information |
|---|
| >gi|256861417|gb|ACV32411.1| lysozyme [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|256861419|gb|ACV32412.1| lysozyme [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|195492651|ref|XP_002094083.1| GE20392 [Drosophila yakuba] gi|194180184|gb|EDW93795.1| GE20392 [Drosophila yakuba] | Back alignment and taxonomy information |
|---|
| >gi|194749625|ref|XP_001957239.1| GF24155 [Drosophila ananassae] gi|190624521|gb|EDV40045.1| GF24155 [Drosophila ananassae] | Back alignment and taxonomy information |
|---|
| >gi|195376757|ref|XP_002047159.1| GJ12084 [Drosophila virilis] gi|194154317|gb|EDW69501.1| GJ12084 [Drosophila virilis] | Back alignment and taxonomy information |
|---|
| >gi|195588547|ref|XP_002084019.1| GD13037 [Drosophila simulans] gi|194196028|gb|EDX09604.1| GD13037 [Drosophila simulans] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 769 | ||||||
| FB|FBgn0035813 | 972 | CG8492 [Drosophila melanogaste | 0.184 | 0.146 | 0.413 | 2e-41 | |
| FB|FBgn0004425 | 140 | LysB "Lysozyme B" [Drosophila | 0.158 | 0.871 | 0.382 | 1.9e-18 | |
| FB|FBgn0004427 | 140 | LysD "Lysozyme D" [Drosophila | 0.141 | 0.778 | 0.393 | 4e-18 | |
| FB|FBgn0004426 | 140 | LysC "Lysozyme C" [Drosophila | 0.141 | 0.778 | 0.393 | 5.1e-18 | |
| FB|FBgn0004430 | 140 | LysS "Lysozyme S" [Drosophila | 0.159 | 0.878 | 0.358 | 6.6e-18 | |
| FB|FBgn0004428 | 140 | LysE "Lysozyme E" [Drosophila | 0.158 | 0.871 | 0.367 | 1.1e-17 | |
| FB|FBgn0004431 | 142 | LysX "Lysozyme X" [Drosophila | 0.162 | 0.880 | 0.352 | 1.1e-17 | |
| FB|FBgn0004429 | 141 | LysP "Lysozyme P" [Drosophila | 0.162 | 0.886 | 0.373 | 1.4e-17 | |
| UNIPROTKB|P81708 | 129 | P81708 "Lysozyme C, milk isozy | 0.154 | 0.922 | 0.379 | 3.7e-17 | |
| UNIPROTKB|G1K265 | 148 | LYZ "Uncharacterized protein" | 0.172 | 0.898 | 0.376 | 7.8e-17 |
| FB|FBgn0035813 CG8492 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 313 (115.2 bits), Expect = 2.0e-41, Sum P(2) = 2.0e-41
Identities = 60/145 (41%), Positives = 87/145 (60%)
Query: 277 EGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQIN 336
+ K + CELAK L + R++PTWVCIA ES+ N+ A N +GS DHG+FQI+
Sbjct: 594 KAKIYNRCELAKELYHRHKFPMREIPTWVCIAEHESSFNTAAVGKLNADGSEDHGLFQIS 653
Query: 337 DKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YC- 394
D YWCT +GK CH +C D++I+DDV C+ IH + R G+GF AW+ Y+ +C
Sbjct: 654 DIYWCTHDQTSGKACHIECDRLLDSDISDDVQCIRTIHEEHTRLSGDGFNAWTVYNGHCR 713
Query: 395 NTN-SKVSTYDHADDMGEVSACACY 418
N N +K+S +++ E + Y
Sbjct: 714 NQNLAKLSDCFDGNEISEADKTSHY 738
|
|
| FB|FBgn0004425 LysB "Lysozyme B" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
| FB|FBgn0004427 LysD "Lysozyme D" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
| FB|FBgn0004426 LysC "Lysozyme C" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
| FB|FBgn0004430 LysS "Lysozyme S" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
| FB|FBgn0004428 LysE "Lysozyme E" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
| FB|FBgn0004431 LysX "Lysozyme X" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
| FB|FBgn0004429 LysP "Lysozyme P" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P81708 P81708 "Lysozyme C, milk isozyme" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|G1K265 LYZ "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 769 | |||
| cd00119 | 123 | cd00119, LYZ1, C-type lysozyme (1, 4-beta-N-acetyl | 2e-35 | |
| smart00263 | 127 | smart00263, LYZ1, Alpha-lactalbumin / lysozyme C | 2e-28 | |
| pfam00062 | 125 | pfam00062, Lys, C-type lysozyme/alpha-lactalbumin | 3e-25 | |
| cd00119 | 123 | cd00119, LYZ1, C-type lysozyme (1, 4-beta-N-acetyl | 7e-22 | |
| smart00263 | 127 | smart00263, LYZ1, Alpha-lactalbumin / lysozyme C | 2e-18 | |
| pfam00062 | 125 | pfam00062, Lys, C-type lysozyme/alpha-lactalbumin | 1e-14 | |
| cd00054 | 38 | cd00054, EGF_CA, Calcium-binding EGF-like domain, | 0.001 | |
| cd00053 | 36 | cd00053, EGF, Epidermal growth factor domain, foun | 0.002 | |
| pfam00008 | 32 | pfam00008, EGF, EGF-like domain | 0.002 |
| >gnl|CDD|238066 cd00119, LYZ1, C-type lysozyme (1, 4-beta-N-acetylmuramidase, LYZ) and alpha-lactalbumin (lactose synthase B protein, LA) | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 51/127 (40%), Positives = 67/127 (52%), Gaps = 9/127 (7%)
Query: 279 KRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDK 338
K F CELAK L R + WVC+A ES N+ A + N +GS D+G+FQIN K
Sbjct: 1 KIFTRCELAKELKRLGLYPGISLANWVCLAEHESGFNTQAVN-NNNDGSTDYGLFQINSK 59
Query: 339 YWCT-ASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YCNT 396
YWC P+G CH CS D++ITDD+ C KI + Q GF AW + +C
Sbjct: 60 YWCNDGKTPSGNICHISCSKLLDDDITDDIKCAKKIVKEHQ-----GFDAWVAWKNHCQ- 113
Query: 397 NSKVSTY 403
+S +
Sbjct: 114 GRDLSQW 120
|
They have a close evolutionary relationship and similar tertiary structure, however, functionally they are quite different. Lysozymes have primarily bacteriolytic function; hydrolysis of peptidoglycan of prokaryotic cell walls and transglycosylation. LA is a calcium-binding metalloprotein that is expressed exclusively in the mammary gland during lactation. LA is the regulatory subunit of the enzyme lactose synthase. The association of LA with the catalytic component of lactose synthase, galactosyltransferase, alters the acceptor substrate specificity of this glycosyltransferase, facilitating biosynthesis of lactose. Length = 123 |
| >gnl|CDD|197612 smart00263, LYZ1, Alpha-lactalbumin / lysozyme C | Back alignment and domain information |
|---|
| >gnl|CDD|200968 pfam00062, Lys, C-type lysozyme/alpha-lactalbumin family | Back alignment and domain information |
|---|
| >gnl|CDD|238066 cd00119, LYZ1, C-type lysozyme (1, 4-beta-N-acetylmuramidase, LYZ) and alpha-lactalbumin (lactose synthase B protein, LA) | Back alignment and domain information |
|---|
| >gnl|CDD|197612 smart00263, LYZ1, Alpha-lactalbumin / lysozyme C | Back alignment and domain information |
|---|
| >gnl|CDD|200968 pfam00062, Lys, C-type lysozyme/alpha-lactalbumin family | Back alignment and domain information |
|---|
| >gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
| >gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
| >gnl|CDD|215652 pfam00008, EGF, EGF-like domain | Back alignment and domain information |
|---|
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 769 | |||
| cd00119 | 123 | LYZ1 C-type lysozyme (1, 4-beta-N-acetylmuramidase | 100.0 | |
| PF00062 | 125 | Lys: C-type lysozyme/alpha-lactalbumin family; Int | 100.0 | |
| smart00263 | 127 | LYZ1 Alpha-lactalbumin / lysozyme C. | 100.0 | |
| smart00263 | 127 | LYZ1 Alpha-lactalbumin / lysozyme C. | 99.94 | |
| cd00119 | 123 | LYZ1 C-type lysozyme (1, 4-beta-N-acetylmuramidase | 99.94 | |
| PF00062 | 125 | Lys: C-type lysozyme/alpha-lactalbumin family; Int | 99.94 | |
| KOG1214|consensus | 1289 | 99.65 | ||
| KOG1219|consensus | 4289 | 99.49 | ||
| KOG1219|consensus | 4289 | 99.43 | ||
| KOG1214|consensus | 1289 | 99.3 | ||
| KOG4289|consensus | 2531 | 99.28 | ||
| KOG1217|consensus | 487 | 99.2 | ||
| KOG1217|consensus | 487 | 99.03 | ||
| KOG4289|consensus | 2531 | 98.99 | ||
| KOG1225|consensus | 525 | 98.77 | ||
| KOG1225|consensus | 525 | 98.47 | ||
| KOG1226|consensus | 783 | 98.28 | ||
| KOG4260|consensus | 350 | 98.21 | ||
| KOG4260|consensus | 350 | 98.2 | ||
| KOG0994|consensus | 1758 | 97.88 | ||
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 97.56 | |
| smart00179 | 39 | EGF_CA Calcium-binding EGF-like domain. | 97.47 | |
| KOG1226|consensus | 783 | 97.38 | ||
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 97.24 | |
| smart00179 | 39 | EGF_CA Calcium-binding EGF-like domain. | 97.24 | |
| KOG0994|consensus | 1758 | 97.11 | ||
| cd00054 | 38 | EGF_CA Calcium-binding EGF-like domain, present in | 97.06 | |
| PRK15328 | 160 | invasion protein IagB; Provisional | 97.04 | |
| PRK13722 | 169 | lytic transglycosylase; Provisional | 96.97 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 96.94 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 96.87 | |
| cd00054 | 38 | EGF_CA Calcium-binding EGF-like domain, present in | 96.76 | |
| PRK13888 | 206 | conjugal transfer protein TrbN; Provisional | 96.62 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 96.46 | |
| cd00053 | 36 | EGF Epidermal growth factor domain, found in epide | 96.35 | |
| PF06247 | 197 | Plasmod_Pvs28: Plasmodium ookinete surface protein | 96.15 | |
| smart00181 | 35 | EGF Epidermal growth factor-like domain. | 96.06 | |
| PF01464 | 121 | SLT: Transglycosylase SLT domain; InterPro: IPR008 | 95.74 | |
| cd00053 | 36 | EGF Epidermal growth factor domain, found in epide | 95.73 | |
| smart00181 | 35 | EGF Epidermal growth factor-like domain. | 95.43 | |
| KOG1836|consensus | 1705 | 95.29 | ||
| PRK13864 | 245 | type IV secretion system lytic transglycosylase Vi | 95.08 | |
| cd00254 | 113 | LT_GEWL Lytic Transglycosylase (LT) and Goose Egg | 94.86 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 94.85 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 94.84 | |
| PF06247 | 197 | Plasmod_Pvs28: Plasmodium ookinete surface protein | 94.2 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 94.07 | |
| PF07974 | 32 | EGF_2: EGF-like domain; InterPro: IPR013111 A sequ | 93.61 | |
| PF07974 | 32 | EGF_2: EGF-like domain; InterPro: IPR013111 A sequ | 93.39 | |
| PF12661 | 13 | hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E | 93.2 | |
| PF06737 | 77 | Transglycosylas: Transglycosylase-like domain; Int | 92.59 | |
| PF12661 | 13 | hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E | 91.67 | |
| cd01021 | 166 | GEWL Goose Egg White Lysozyme domain. Eukaryotic " | 90.62 | |
| smart00051 | 63 | DSL delta serrate ligand. | 89.98 | |
| KOG1836|consensus | 1705 | 89.65 | ||
| KOG1218|consensus | 316 | 87.26 | ||
| PRK13888 | 206 | conjugal transfer protein TrbN; Provisional | 85.88 | |
| PHA03099 | 139 | epidermal growth factor-like protein (EGF-like pro | 85.57 | |
| PF14670 | 36 | FXa_inhibition: Coagulation Factor Xa inhibitory s | 85.38 | |
| PHA02887 | 126 | EGF-like protein; Provisional | 84.28 | |
| PF14670 | 36 | FXa_inhibition: Coagulation Factor Xa inhibitory s | 83.39 | |
| smart00051 | 63 | DSL delta serrate ligand. | 81.39 | |
| cd01475 | 224 | vWA_Matrilin VWA_Matrilin: In cartilaginous plate, | 81.14 | |
| PHA03099 | 139 | epidermal growth factor-like protein (EGF-like pro | 80.79 | |
| PRK15470 | 203 | emtA lytic murein endotransglycosylase E; Provisio | 80.78 | |
| KOG3516|consensus | 1306 | 80.57 |
| >cd00119 LYZ1 C-type lysozyme (1, 4-beta-N-acetylmuramidase, LYZ) and alpha-lactalbumin (lactose synthase B protein, LA) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=347.78 Aligned_cols=119 Identities=42% Similarity=0.834 Sum_probs=112.5
Q ss_pred eeecchHHHHHHHHhcCC-CCCCcccceEeeccccCCCcccccCCCCCCCceeeeeeeccccccCCCCC-Cccccccccc
Q psy9686 279 KRFGACELAKFLVRQRGI-ARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGP-AGKECHAKCS 356 (769)
Q Consensus 279 k~~~rCela~~l~~~~g~-~~~~l~~wvCla~~eS~~~t~a~~~~~~~gs~~yGifQIn~~~WC~~~~~-~~~~C~~~C~ 356 (769)
|||+|||||++|++ +|| ++.+|++|||||++||+|||+|+++ |.|||+||||||||++|||+++++ ++|.|+|+|+
T Consensus 1 k~~~rCeLa~~L~~-~g~~~~~~l~~Wvcia~~ES~~nt~a~~~-n~~gs~dyGlfQINs~~WC~~~~~~~~n~C~i~C~ 78 (123)
T cd00119 1 KIFTRCELAKELKR-LGLYPGISLANWVCLAEHESGFNTQAVNN-NNDGSTDYGLFQINSKYWCNDGKTPSGNICHISCS 78 (123)
T ss_pred CcCcHhHHHHHHHH-cCCCCCCCHHHHHHHHHHHHCCCccceec-CCCCCeeEeEEEecchhhccCCCCCCCCCcCCCHH
Confidence 79999999999998 576 9999999999999999999999995 679999999999999999999876 5899999999
Q ss_pred cccCCChhHHHHHHHHHHhcccccccCcccccccCc-cccCCCCCccccc
Q psy9686 357 SFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YCNTNSKVSTYDH 405 (769)
Q Consensus 357 ~ll~~di~~~i~Cak~i~~~~~~~~~~G~~aW~~w~-~C~g~~~l~~~~~ 405 (769)
+||+|||+|||+|||+|+++| +||+||++|+ +|+|+ +|++|..
T Consensus 79 ~Ll~ddI~~~i~CAk~I~~~~-----~G~~aW~~w~~~C~g~-~L~~~~~ 122 (123)
T cd00119 79 KLLDDDITDDIKCAKKIVKEH-----QGFDAWVAWKNHCQGR-DLSQWVK 122 (123)
T ss_pred HhccccHHHHHHHHHHHHhcC-----CCchhHHHHHHhCCCC-CCccccC
Confidence 999999999999999999996 7999999999 99997 9999963
|
They have a close evolutionary relationship and similar tertiary structure, however, functionally they are quite different. Lysozymes have primarily bacteriolytic function; hydrolysis of peptidoglycan of prokaryotic cell walls and transglycosylation. LA is a calcium-binding metalloprotein that is expressed exclusively in the mammary gland during lactation. LA is the regulatory subunit of the enzyme lactose synthase. The association of LA with the catalytic component of lactose synthase, galactosyltransferase, alters the acceptor substrate specificity of this glycosyltransferase, facilitating biosynthesis of lactose. |
| >PF00062 Lys: C-type lysozyme/alpha-lactalbumin family; InterPro: IPR001916 O-Glycosyl hydrolases 3 | Back alignment and domain information |
|---|
| >smart00263 LYZ1 Alpha-lactalbumin / lysozyme C | Back alignment and domain information |
|---|
| >smart00263 LYZ1 Alpha-lactalbumin / lysozyme C | Back alignment and domain information |
|---|
| >cd00119 LYZ1 C-type lysozyme (1, 4-beta-N-acetylmuramidase, LYZ) and alpha-lactalbumin (lactose synthase B protein, LA) | Back alignment and domain information |
|---|
| >PF00062 Lys: C-type lysozyme/alpha-lactalbumin family; InterPro: IPR001916 O-Glycosyl hydrolases 3 | Back alignment and domain information |
|---|
| >KOG1214|consensus | Back alignment and domain information |
|---|
| >KOG1219|consensus | Back alignment and domain information |
|---|
| >KOG1219|consensus | Back alignment and domain information |
|---|
| >KOG1214|consensus | Back alignment and domain information |
|---|
| >KOG4289|consensus | Back alignment and domain information |
|---|
| >KOG1217|consensus | Back alignment and domain information |
|---|
| >KOG1217|consensus | Back alignment and domain information |
|---|
| >KOG4289|consensus | Back alignment and domain information |
|---|
| >KOG1225|consensus | Back alignment and domain information |
|---|
| >KOG1225|consensus | Back alignment and domain information |
|---|
| >KOG1226|consensus | Back alignment and domain information |
|---|
| >KOG4260|consensus | Back alignment and domain information |
|---|
| >KOG4260|consensus | Back alignment and domain information |
|---|
| >KOG0994|consensus | Back alignment and domain information |
|---|
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >smart00179 EGF_CA Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
| >KOG1226|consensus | Back alignment and domain information |
|---|
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >smart00179 EGF_CA Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
| >KOG0994|consensus | Back alignment and domain information |
|---|
| >cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
| >PRK15328 invasion protein IagB; Provisional | Back alignment and domain information |
|---|
| >PRK13722 lytic transglycosylase; Provisional | Back alignment and domain information |
|---|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
| >cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
| >PRK13888 conjugal transfer protein TrbN; Provisional | Back alignment and domain information |
|---|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
| >cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
| >PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium | Back alignment and domain information |
|---|
| >smart00181 EGF Epidermal growth factor-like domain | Back alignment and domain information |
|---|
| >PF01464 SLT: Transglycosylase SLT domain; InterPro: IPR008258 Bacterial lytic transglycosylases degrade murein via cleavage of the beta-1,4-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine, with the concomitant formation of a 1,6-anhydrobond in the muramic acid residue | Back alignment and domain information |
|---|
| >cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
| >smart00181 EGF Epidermal growth factor-like domain | Back alignment and domain information |
|---|
| >KOG1836|consensus | Back alignment and domain information |
|---|
| >PRK13864 type IV secretion system lytic transglycosylase VirB1; Provisional | Back alignment and domain information |
|---|
| >cd00254 LT_GEWL Lytic Transglycosylase (LT) and Goose Egg White Lysozyme (GEWL) domain | Back alignment and domain information |
|---|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
| >PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium | Back alignment and domain information |
|---|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
| >PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A | Back alignment and domain information |
|---|
| >PF06737 Transglycosylas: Transglycosylase-like domain; InterPro: IPR010618 This family of proteins is very likely to act as transglycosylase enzymes related to IPR001916 from INTERPRO and IPR008258 from INTERPRO | Back alignment and domain information |
|---|
| >PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A | Back alignment and domain information |
|---|
| >cd01021 GEWL Goose Egg White Lysozyme domain | Back alignment and domain information |
|---|
| >smart00051 DSL delta serrate ligand | Back alignment and domain information |
|---|
| >KOG1836|consensus | Back alignment and domain information |
|---|
| >KOG1218|consensus | Back alignment and domain information |
|---|
| >PRK13888 conjugal transfer protein TrbN; Provisional | Back alignment and domain information |
|---|
| >PHA03099 epidermal growth factor-like protein (EGF-like protein); Provisional | Back alignment and domain information |
|---|
| >PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A | Back alignment and domain information |
|---|
| >PHA02887 EGF-like protein; Provisional | Back alignment and domain information |
|---|
| >PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A | Back alignment and domain information |
|---|
| >smart00051 DSL delta serrate ligand | Back alignment and domain information |
|---|
| >cd01475 vWA_Matrilin VWA_Matrilin: In cartilaginous plate, extracellular matrix molecules mediate cell-matrix and matrix-matrix interactions thereby providing tissue integrity | Back alignment and domain information |
|---|
| >PHA03099 epidermal growth factor-like protein (EGF-like protein); Provisional | Back alignment and domain information |
|---|
| >PRK15470 emtA lytic murein endotransglycosylase E; Provisional | Back alignment and domain information |
|---|
| >KOG3516|consensus | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 769 | ||||
| 2fbd_A | 122 | The Crystallographic Structure Of The Digestive Lys | 4e-19 | ||
| 3cb7_A | 126 | The Crystallographic Structure Of The Digestive Lys | 7e-17 | ||
| 1iiz_A | 120 | Crystal Structure Of The Induced Antibacterial Prot | 1e-16 | ||
| 1qqy_A | 130 | X-Ray Crystal Structure Analysis Of Canine Milk Lys | 3e-16 | ||
| 1el1_A | 130 | X-Ray Crystal Structure Analysis Of Canine Milk Lys | 3e-16 | ||
| 2cwi_A | 129 | X-Ray Crystal Structure Analysis Of Recombinant Wil | 4e-16 | ||
| 2lhm_A | 130 | Crystal Structures Of The Apo-And Holomutant Human | 1e-15 | ||
| 1i22_A | 130 | Mutant Human Lysozyme (A83kQ86DA92D) Length = 130 | 2e-15 | ||
| 2rsc_A | 120 | Solution Structure Of The Bombyx Mori Lysozyme Leng | 2e-15 | ||
| 3b6l_A | 147 | Crystal Structure Of Lysozyme Folded In Sds And 2-M | 4e-15 | ||
| 1i20_A | 130 | Mutant Human Lysozyme (A92d) Length = 130 | 7e-15 | ||
| 1gfg_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 7e-15 | ||
| 1di3_A | 130 | Role Of Amino Acid Residues At Turns In The Conform | 7e-15 | ||
| 2z2e_A | 129 | Crystal Structure Of Canine Milk Lysozyme Stabilize | 7e-15 | ||
| 1gd6_A | 119 | Structure Of The Bombyx Mori Lysozyme Length = 119 | 8e-15 | ||
| 1i1z_A | 130 | Mutant Human Lysozyme (Q86d) Length = 130 | 9e-15 | ||
| 1c7p_A | 134 | Crystal Structure Of Mutant Human Lysozyme With Fou | 9e-15 | ||
| 1c46_A | 131 | Mutant Human Lysozyme With Foreign N-Terminal Resid | 1e-14 | ||
| 1gb5_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 1e-14 | ||
| 2eql_A | 129 | Crystallographic Studies Of A Calcium Binding Lysoz | 1e-14 | ||
| 1lhi_A | 130 | Role Of Proline Residues In Human Lysozyme Stabilit | 2e-14 | ||
| 1b5u_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 2e-14 | ||
| 1lsy_A | 147 | Crystal Structure Of The Mutant D52s Hen Egg White | 2e-14 | ||
| 1ouc_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 3e-14 | ||
| 1cj7_A | 130 | T11v Mutant Human Lysozyme Length = 130 | 3e-14 | ||
| 1gdx_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 3e-14 | ||
| 1gfv_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 3e-14 | ||
| 1d6q_A | 130 | Human Lysozyme E102 Mutant Labelled With 2',3'-Epox | 3e-14 | ||
| 1gfe_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 4e-14 | ||
| 1gfj_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 4e-14 | ||
| 1oub_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 4e-14 | ||
| 1bb3_A | 130 | Human Lysozyme Mutant A96l Length = 130 | 4e-14 | ||
| 1lhj_A | 130 | Role Of Proline Residues In Human Lysozyme Stabilit | 4e-14 | ||
| 1gf8_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 4e-14 | ||
| 1gfu_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 4e-14 | ||
| 1gf3_A | 130 | Buried Polar Mutant Human Lysozyme Length = 130 | 4e-14 | ||
| 1ip3_A | 130 | G68a Human Lysozyme Length = 130 | 4e-14 | ||
| 1gbo_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 4e-14 | ||
| 1gf7_A | 130 | Buried Polar Mutant Human Lysozyme Length = 130 | 4e-14 | ||
| 1ip6_A | 130 | G127a Human Lysozyme Length = 130 | 4e-14 | ||
| 1gb2_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 4e-14 | ||
| 1oug_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 5e-14 | ||
| 1b7m_A | 130 | Verification Of Spmp Using Mutant Human Lysozymes L | 5e-14 | ||
| 1ioc_A | 134 | Crystal Structure Of Mutant Human Lysozyme, Eaea-I5 | 5e-14 | ||
| 1gfa_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 5e-14 | ||
| 1cj6_A | 130 | T11a Mutant Human Lysozyme Length = 130 | 5e-14 | ||
| 1inu_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 5e-14 | ||
| 3ln2_A | 130 | Crystal Structure Of A Charge Engineered Human Lyso | 5e-14 | ||
| 1lhh_A | 130 | Role Of Proline Residues In Human Lysozyme Stabilit | 5e-14 | ||
| 1cj8_A | 130 | T40a Mutant Human Lysozyme Length = 130 | 5e-14 | ||
| 1ckf_A | 130 | T52a Mutant Human Lysozyme Length = 130 | 5e-14 | ||
| 2hea_A | 130 | Contribution Of Water Molecules In The Interior Of | 5e-14 | ||
| 1ckc_A | 130 | T43a Mutant Human Lysozyme Length = 130 | 5e-14 | ||
| 1gf9_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 5e-14 | ||
| 1b5x_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 5e-14 | ||
| 1b7o_A | 130 | Verification Of Spmp Using Mutant Human Lysozymes L | 5e-14 | ||
| 1ouh_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 5e-14 | ||
| 1eqe_A | 130 | Crystal Structures Of Salt Bridge Mutants Of Human | 5e-14 | ||
| 1gb0_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1ge0_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1gfr_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1gb6_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1gay_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 133l_A | 130 | Role Of Arg 115 In The Catalytic Action Of Human Ly | 6e-14 | ||
| 1eq5_A | 130 | Crystal Structures Of Salt Bridge Mutants Of Human | 6e-14 | ||
| 1gby_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1b7q_A | 130 | Verification Of Spmp Using Mutant Human Lysozymes L | 6e-14 | ||
| 1gb7_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1gb9_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1lzs_A | 130 | Structural Changes Of The Active Site Cleft And Dif | 6e-14 | ||
| 1ouf_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 6e-14 | ||
| 1oue_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 6e-14 | ||
| 1gb8_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1gfk_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1lyy_A | 130 | Amyloidogenic Variant (Asp67his) Of Human Lysozyme | 6e-14 | ||
| 1ip7_A | 130 | G129a Human Lysozyme Length = 130 | 6e-14 | ||
| 1ckh_A | 130 | T70v Mutant Human Lysozyme Length = 130 | 6e-14 | ||
| 1ckg_A | 130 | T52v Mutant Human Lysozyme Length = 130 | 6e-14 | ||
| 134l_A | 130 | Role Of Arg 115 In The Catalytic Action Of Human Ly | 6e-14 | ||
| 1ckd_A | 130 | T43v Mutant Human Lysozyme Length = 130 | 6e-14 | ||
| 1gfh_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1b7s_A | 130 | Verification Of Spmp Using Mutant Human Lysozymes L | 6e-14 | ||
| 1wqp_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 6e-14 | ||
| 1gft_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-14 | ||
| 1gb3_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 7e-14 | ||
| 1wqn_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 7e-14 | ||
| 1gaz_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 7e-14 | ||
| 1lhl_A | 130 | Role Of Proline Residues In Human Lysozyme Stabilit | 7e-14 | ||
| 1b5w_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 7e-14 | ||
| 1gbw_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 7e-14 | ||
| 1wqo_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 7e-14 | ||
| 1gbz_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 7e-14 | ||
| 1yam_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 7e-14 | ||
| 1gbx_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 8e-14 | ||
| 1w08_A | 130 | Structure Of T70n Human Lysozyme Length = 130 | 8e-14 | ||
| 1ip4_A | 130 | G72a Human Lysozyme Length = 130 | 8e-14 | ||
| 1ip1_A | 130 | G37a Human Lysozyme Length = 130 | 8e-14 | ||
| 2heb_A | 130 | Contribution Of Water Molecules In The Interior Of | 9e-14 | ||
| 1gdw_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 9e-14 | ||
| 1yao_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 9e-14 | ||
| 1yap_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 9e-14 | ||
| 1yan_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 9e-14 | ||
| 1yaq_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 9e-14 | ||
| 1gf5_A | 130 | Buried Polar Mutant Human Lysozyme Length = 130 | 9e-14 | ||
| 1b5y_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 1e-13 | ||
| 1b5v_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 1e-13 | ||
| 1c43_A | 130 | Mutant Human Lysozyme With Foreign N-Terminal Resid | 1e-13 | ||
| 1b5z_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 1e-13 | ||
| 1cj9_A | 130 | T40v Mutant Human Lysozyme Length = 130 | 1e-13 | ||
| 1c45_A | 130 | Mutant Human Lysozyme With Foreign N-Terminal Resid | 1e-13 | ||
| 1jkc_A | 130 | Human Lysozyme Mutant With Trp 109 Replaced By Phe | 1e-13 | ||
| 1wqq_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 1e-13 | ||
| 2mee_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 1e-13 | ||
| 2meb_A | 130 | Changes In Conformational Stability Of A Series Of | 1e-13 | ||
| 2mef_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 1e-13 | ||
| 2mec_A | 130 | Changes In Conformational Stability Of A Series Of | 1e-13 | ||
| 1gf0_A | 130 | Buried Polar Mutant Human Lysozyme Length = 130 | 1e-13 | ||
| 1gez_A | 130 | Buried Polar Mutant Human Lysozyme Length = 130 | 1e-13 | ||
| 1lz5_A | 134 | Structural And Functional Analyses Of The Arg-Gly-A | 1e-13 | ||
| 1eq4_A | 130 | Crystal Structures Of Salt Bridge Mutants Of Human | 1e-13 | ||
| 1ge3_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 1e-13 | ||
| 1ge4_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 1e-13 | ||
| 1jka_A | 130 | Human Lysozyme Mutant With Glu 35 Replaced By Asp L | 1e-13 | ||
| 1tcy_A | 130 | Dissection Of The Functional Role Of Structural Ele | 1e-13 | ||
| 1wqm_A | 130 | Contribution Of Hydrogen Bonds To The Conformationa | 1e-13 | ||
| 1gf6_A | 130 | Buried Polar Mutant Human Lysozyme Length = 130 | 2e-13 | ||
| 1ip5_A | 130 | G105a Human Lysozyme Length = 130 | 2e-13 | ||
| 1ouj_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 2e-13 | ||
| 1oui_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 2e-13 | ||
| 1oud_A | 130 | Contribution Of Hydrophobic Residues To The Stabili | 2e-13 | ||
| 1gf4_A | 130 | Buried Polar Mutant Human Lysozyme Length = 130 | 2e-13 | ||
| 2mea_A | 130 | Changes In Conformational Stability Of A Series Of | 2e-13 | ||
| 2med_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 2e-13 | ||
| 1tdy_A | 130 | Dissection Of The Functional Role Of Structural Ele | 2e-13 | ||
| 1laa_A | 130 | X-Ray Structure Of Glu 53 Human Lysozyme Length = 1 | 2e-13 | ||
| 1di5_A | 129 | Role Of Amino Acid Residues At Turns In The Conform | 2e-13 | ||
| 1b7l_A | 130 | Verification Of Spmp Using Mutant Human Lysozymes L | 2e-13 | ||
| 2meh_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 2e-13 | ||
| 1loz_A | 130 | Amyloidogenic Variant (I56t) Variant Of Human Lysoz | 2e-13 | ||
| 1gev_A | 130 | Buried Polar Mutant Human Lysozyme Length = 130 | 3e-13 | ||
| 2hec_A | 130 | Contribution Of Water Molecules In The Interior Of | 3e-13 | ||
| 2hef_A | 130 | Contribution Of Water Molecules In The Interior Of | 3e-13 | ||
| 2hed_A | 130 | Contribution Of Water Molecules In The Interior Of | 3e-13 | ||
| 1ip2_A | 130 | G48a Human Lysozyme Length = 130 | 3e-13 | ||
| 2mei_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 3e-13 | ||
| 1jkb_A | 130 | Human Lysozyme Mutant With Glu 35 Replaced By Ala L | 3e-13 | ||
| 1ge1_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 3e-13 | ||
| 1bb4_A | 130 | Human Lysozyme Double Mutant A96l, W109h Length = 1 | 3e-13 | ||
| 1d6p_A | 130 | Human Lysozyme L63 Mutant Labelled With 2',3'-Epoxy | 4e-13 | ||
| 1b7r_A | 130 | Verification Of Spmp Using Mutant Human Lysozymes L | 4e-13 | ||
| 2meg_A | 130 | Changes In Conformational Stability Of A Series Of | 4e-13 | ||
| 1lz6_A | 138 | Structural And Functional Analyses Of The Arg-Gly-A | 4e-13 | ||
| 1lmt_A | 136 | Structure Of A Conformationally Constrained Arg-Gly | 4e-13 | ||
| 208l_A | 130 | Mutant Human Lysozyme C77a Length = 130 | 4e-13 | ||
| 1lhk_A | 130 | Role Of Proline Residues In Human Lysozyme Stabilit | 5e-13 | ||
| 1b7n_A | 130 | Verification Of Spmp Using Mutant Human Lysozymes L | 5e-13 | ||
| 1jkd_A | 130 | Human Lysozyme Mutant With Trp 109 Replaced By Ala | 5e-13 | ||
| 2hee_A | 130 | Contribution Of Water Molecules In The Interior Of | 5e-13 | ||
| 1tay_A | 130 | Dissection Of The Functional Role Of Structural Ele | 5e-13 | ||
| 1ge2_A | 130 | Crystal Structure Of Mutant Human Lysozyme Substitu | 6e-13 | ||
| 1b7p_A | 130 | Verification Of Spmp Using Mutant Human Lysozymes L | 7e-13 | ||
| 2bqh_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 1e-12 | ||
| 1ghl_A | 130 | The Three-Dimensional Structure Of Pheasant And Gui | 2e-12 | ||
| 2bql_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 2e-12 | ||
| 1di4_A | 128 | Role Of Amino Acid Residues At Turns In The Conform | 3e-12 | ||
| 2bqm_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 3e-12 | ||
| 1lhm_A | 130 | The Crystal Structure Of A Mutant Lysozyme C77(Slas | 3e-12 | ||
| 2bqk_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 3e-12 | ||
| 2bqj_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 3e-12 | ||
| 1ior_A | 129 | Stabilization Of Hen Egg White Lysozyme By A Cavity | 3e-12 | ||
| 2bqb_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 4e-12 | ||
| 2bqd_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 5e-12 | ||
| 2bqe_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 5e-12 | ||
| 2bqc_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 5e-12 | ||
| 1lzd_A | 129 | Dissection Of Protein-Carbohydrate Interactions In | 7e-12 | ||
| 2bqi_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 1e-11 | ||
| 1her_A | 129 | Structural And Thermodynamic Analysis Of Compensati | 1e-11 | ||
| 1ioq_A | 129 | Stabilization Of Hen Egg White Lysozyme By A Cavity | 1e-11 | ||
| 1nby_C | 129 | Crystal Structure Of Hyhel-63 Complexed With Hel Mu | 1e-11 | ||
| 1iot_A | 129 | Stabilization Of Hen Egg White Lysozyme By A Cavity | 1e-11 | ||
| 1qsw_A | 130 | Crystal Structure Analysis Of A Human Lysozyme Muta | 1e-11 | ||
| 1heq_A | 129 | Structural And Thermodynamic Analysis Of Compensati | 1e-11 | ||
| 1ix0_A | 130 | I59a-3ss Human Lysozyme Length = 130 | 1e-11 | ||
| 1flu_A | 129 | Hen Egg White Lysozyme Mutant With Alanine Substitu | 2e-11 | ||
| 132l_A | 129 | Structural Consequences Of Reductive Methylation Of | 2e-11 | ||
| 1a2y_C | 129 | Hen Egg White Lysozyme, D18a Mutant, In Complex Wit | 2e-11 | ||
| 1flw_A | 129 | Hen Egg White Lysozyme Mutant With Alanine Substitu | 2e-11 | ||
| 1bql_Y | 129 | Structure Of An Anti-Hel Fab Fragment Complexed Wit | 2e-11 | ||
| 1ir7_A | 129 | Im Mutant Of Lysozyme Length = 129 | 2e-11 | ||
| 2iff_Y | 129 | Structure Of An Antibody-Lysozyme Complex: Effect O | 2e-11 | ||
| 1kxx_A | 129 | Analysis Of The Stabilization Of Hen Lysozyme With | 2e-11 | ||
| 1kxw_A | 129 | Analysis Of The Stabilization Of Hen Lysozyme With | 2e-11 | ||
| 1uia_A | 127 | Analysis Of The Stabilization Of Hen Lysozyme With | 2e-11 | ||
| 1hep_A | 129 | Structural And Thermodynamic Analysis Of Compensati | 2e-11 | ||
| 1lzg_A | 129 | Dissection Of Protein-Carbohydrate Interactions In | 2e-11 | ||
| 1jhl_A | 129 | Three-Dimensional Structure Of A Heteroclitic Antig | 2e-11 | ||
| 1flq_A | 129 | Hen Egg White Lysozyme Mutant With Alanine Substitu | 2e-11 | ||
| 1fbi_X | 129 | Crystal Structure Of A Cross-Reaction Complex Betwe | 2e-11 | ||
| 1fdl_Y | 129 | Crystallographic Refinement Of The Three-Dimensiona | 2e-11 | ||
| 1uic_A | 129 | Analysis Of The Stabilization Of Hen Lysozyme With | 2e-11 | ||
| 1kxy_A | 129 | Analysis Of The Stabilization Of Hen Lysozyme With | 2e-11 | ||
| 1hem_A | 129 | Structural And Thermodynamic Analysis Of Compensati | 3e-11 | ||
| 1at6_A | 129 | Hen Egg White Lysozyme With A Isoaspartate Residue | 3e-11 | ||
| 1v7s_A | 129 | Triclinic Hen Lysozyme Crystallized At 313k From A | 3e-11 | ||
| 1uid_A | 129 | Analysis Of The Stabilization Of Hen Lysozyme With | 3e-11 | ||
| 1lsg_A | 144 | Three-Dimensional Structure Of The Platelet Integri | 3e-11 | ||
| 1lsn_A | 129 | Thermal Stability Determinants Of Chicken Egg-White | 3e-11 | ||
| 1uif_A | 129 | Analysis Of The Stabilization Of Hen Lysozyme With | 3e-11 | ||
| 1uie_A | 129 | Analysis Of The Stabilization Of Hen Lysozyme With | 3e-11 | ||
| 3qy4_A | 129 | Crystallization And In Situ Data Collection Of Lyso | 3e-11 | ||
| 1heo_A | 129 | Structural And Thermodynamic Analysis Of Compensati | 3e-11 | ||
| 1ivm_A | 130 | Solution Structure Of Mouse Lysozyme M Length = 130 | 3e-11 | ||
| 1io5_A | 129 | Hydrogen And Hydration Of Hen Egg-White Lysozyme De | 4e-11 | ||
| 1hen_A | 129 | Structural And Thermodynamic Analysis Of Compensati | 4e-11 | ||
| 1ios_A | 129 | Stabilization Of Hen Egg White Lysozyme By A Cavity | 4e-11 | ||
| 1ir9_A | 129 | Im Mutant Of Lysozyme Length = 129 | 5e-11 | ||
| 1ir8_A | 129 | Im Mutant Of Lysozyme Length = 129 | 5e-11 | ||
| 1lsm_A | 129 | Thermal Stability Determinants Of Chicken Egg-White | 5e-11 | ||
| 1ndg_C | 129 | Crystal Structure Of Fab Fragment Of Antibody Hyhel | 5e-11 | ||
| 1h6m_A | 129 | Covalent Glycosyl-Enzyme Intermediate Of Hen Egg Wh | 6e-11 | ||
| 1dzb_X | 129 | Crystal Structure Of Phage Library-Derived Single-C | 7e-11 | ||
| 1hhl_A | 129 | The Three-Dimensional Structure Of Pheasant And Gui | 7e-11 | ||
| 3a3q_A | 129 | Structure Of N59d Hen Egg-White Lysozyme In Complex | 7e-11 | ||
| 3ojp_A | 129 | D52n Mutant Of Hen Egg White Lysozyme (Hewl) Length | 9e-11 | ||
| 1fly_A | 129 | Hen Egg White Lysozyme Mutant With Alanine Substitu | 1e-10 | ||
| 1nbz_C | 129 | Crystal Structure Of Hyhel-63 Complexed With Hel Mu | 1e-10 | ||
| 1lz2_A | 129 | Crystallographic Study Of Turkey Egg-White Lysozyme | 1e-10 | ||
| 1fn5_A | 129 | Hen Egg White Lysozyme Mutant With Alanine Substitu | 1e-10 | ||
| 3ok0_A | 129 | E35a Mutant Of Hen Egg White Lysozyme (Hewl) Length | 1e-10 | ||
| 1at5_A | 129 | Hen Egg White Lysozyme With A Succinimide Residue L | 1e-10 | ||
| 1bb6_A | 129 | Lysozyme Complex With 4-Methyl-Umbelliferyl Chitotr | 1e-10 | ||
| 2z2f_A | 129 | X-Ray Crystal Structure Of Bovine Stomach Lysozyme | 5e-10 | ||
| 2bqn_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 8e-10 | ||
| 2ihl_A | 129 | Lysozyme (e.c.3.2.1.17) (japanese Quail) Length = 1 | 1e-09 | ||
| 2gv0_A | 131 | The Structure Of The Orthorhombic Form Of Soft-Shel | 1e-09 | ||
| 2bqo_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 3e-09 | ||
| 2bqg_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 3e-09 | ||
| 1hml_A | 142 | Alpha_lactalbumin Possesses A Distinct Zinc Binding | 1e-08 | ||
| 2bqf_A | 130 | Contribution Of Hydrophobic Effect To The Conformat | 1e-08 | ||
| 1hfz_A | 124 | Alpha-Lactalbumin Length = 124 | 1e-08 | ||
| 1f6r_A | 123 | Crystal Structure Of Apo-Bovine Alpha-Lactalbumin L | 2e-08 | ||
| 1fkv_A | 124 | Recombinant Goat Alpha-Lactalbumin T29i Length = 12 | 2e-08 | ||
| 1fkq_A | 124 | Recombinant Goat Alpha-Lactalbumin T29v Length = 12 | 3e-08 | ||
| 2goi_A | 138 | Crystal Structure Of Mouse Sperm C-Type Lysozyme-Li | 4e-08 | ||
| 1a4v_A | 123 | Alpha-Lactalbumin Length = 123 | 5e-08 | ||
| 3b0i_A | 124 | Crystal Structure Of Recombinant Human Alpha Lactal | 5e-08 | ||
| 1hmk_A | 124 | Recombinant Goat Alpha-Lactalbumin Length = 124 | 9e-08 | ||
| 1hfy_A | 123 | Alpha-Lactalbumin Length = 123 | 1e-07 | ||
| 3b0k_A | 123 | Crystal Structure Of Alpha-Lactalbumin Length = 123 | 1e-07 | ||
| 1alc_A | 123 | Refined Structure Of Baboon Alpha-Lactalbumin At 1. | 1e-07 | ||
| 1b9o_A | 123 | Human Alpha-Lactalbumin, Low Temperature Form Lengt | 1e-07 | ||
| 3b0o_A | 123 | Crystal Structure Of Alpha-Lactalbumin Length = 123 | 2e-07 | ||
| 1jug_A | 125 | Lysozyme From Echidna Milk (Tachyglossus Aculeatus) | 9e-07 | ||
| 3zvq_A | 70 | Crystal Structure Of Proteolyzed Lysozyme Length = | 3e-06 | ||
| 2vj3_A | 135 | Human Notch-1 Egfs 11-13 Length = 135 | 1e-04 | ||
| 1toz_A | 116 | Nmr Structure Of The Human Notch-1 Ligand Binding R | 5e-04 |
| >pdb|2FBD|A Chain A, The Crystallographic Structure Of The Digestive Lysozyme 1 From Musca Domestica At 1.90 Ang. Length = 122 | Back alignment and structure |
|
| >pdb|3CB7|A Chain A, The Crystallographic Structure Of The Digestive Lysozyme 2 From Musca Domestica At 1.9 Ang. Length = 126 | Back alignment and structure |
| >pdb|1IIZ|A Chain A, Crystal Structure Of The Induced Antibacterial Protein From Tasar Silkworm, Antheraea Mylitta Length = 120 | Back alignment and structure |
| >pdb|1QQY|A Chain A, X-Ray Crystal Structure Analysis Of Canine Milk Lysozyme (Apo-Type) Length = 130 | Back alignment and structure |
| >pdb|1EL1|A Chain A, X-Ray Crystal Structure Analysis Of Canine Milk Lysozyme (Holo-Type) Length = 130 | Back alignment and structure |
| >pdb|2CWI|A Chain A, X-Ray Crystal Structure Analysis Of Recombinant Wild-Type Canine Milk Lysozyme (Apo-Type) Length = 129 | Back alignment and structure |
| >pdb|2LHM|A Chain A, Crystal Structures Of The Apo-And Holomutant Human Lysozymes With An Introduced Ca2+ Binding Site Length = 130 | Back alignment and structure |
| >pdb|1I22|A Chain A, Mutant Human Lysozyme (A83kQ86DA92D) Length = 130 | Back alignment and structure |
| >pdb|2RSC|A Chain A, Solution Structure Of The Bombyx Mori Lysozyme Length = 120 | Back alignment and structure |
| >pdb|3B6L|A Chain A, Crystal Structure Of Lysozyme Folded In Sds And 2-Methyl-2, 4-Pentanediol Length = 147 | Back alignment and structure |
| >pdb|1I20|A Chain A, Mutant Human Lysozyme (A92d) Length = 130 | Back alignment and structure |
| >pdb|1GFG|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1DI3|A Chain A, Role Of Amino Acid Residues At Turns In The Conformational Stability And Folding Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2Z2E|A Chain A, Crystal Structure Of Canine Milk Lysozyme Stabilized Against Non-Enzymatic Deamidation Length = 129 | Back alignment and structure |
| >pdb|1GD6|A Chain A, Structure Of The Bombyx Mori Lysozyme Length = 119 | Back alignment and structure |
| >pdb|1I1Z|A Chain A, Mutant Human Lysozyme (Q86d) Length = 130 | Back alignment and structure |
| >pdb|1C7P|A Chain A, Crystal Structure Of Mutant Human Lysozyme With Four Extra Residues (Eaea) At The N-Terminal Length = 134 | Back alignment and structure |
| >pdb|1C46|A Chain A, Mutant Human Lysozyme With Foreign N-Terminal Residues Length = 131 | Back alignment and structure |
| >pdb|1GB5|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|2EQL|A Chain A, Crystallographic Studies Of A Calcium Binding Lysozyme From Equine Milk At 2.5 Angstroms Resolution Length = 129 | Back alignment and structure |
| >pdb|1LHI|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 | Back alignment and structure |
| >pdb|1B5U|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutant Length = 130 | Back alignment and structure |
| >pdb|1LSY|A Chain A, Crystal Structure Of The Mutant D52s Hen Egg White Lysozyme With An Oligosaccharide Product Length = 147 | Back alignment and structure |
| >pdb|1OUC|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V110a Mutant Length = 130 | Back alignment and structure |
| >pdb|1CJ7|A Chain A, T11v Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GDX|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 | Back alignment and structure |
| >pdb|1GFV|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1D6Q|A Chain A, Human Lysozyme E102 Mutant Labelled With 2',3'-Epoxypropyl Glycoside Of N-Acetyllactosamine Length = 130 | Back alignment and structure |
| >pdb|1GFE|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GFJ|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1OUB|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-ray Structure Of The V100a Mutant Length = 130 | Back alignment and structure |
| >pdb|1BB3|A Chain A, Human Lysozyme Mutant A96l Length = 130 | Back alignment and structure |
| >pdb|1LHJ|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 | Back alignment and structure |
| >pdb|1GF8|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GFU|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GF3|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1IP3|A Chain A, G68a Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GBO|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GF7|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1IP6|A Chain A, G127a Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GB2|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1OUG|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V2a Mutant Length = 130 | Back alignment and structure |
| >pdb|1B7M|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 | Back alignment and structure |
| >pdb|1IOC|A Chain A, Crystal Structure Of Mutant Human Lysozyme, Eaea-I56t Length = 134 | Back alignment and structure |
| >pdb|1GFA|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1CJ6|A Chain A, T11a Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1INU|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|3LN2|A Chain A, Crystal Structure Of A Charge Engineered Human Lysozyme Variant Length = 130 | Back alignment and structure |
| >pdb|1LHH|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 | Back alignment and structure |
| >pdb|1CJ8|A Chain A, T40a Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1CKF|A Chain A, T52a Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2HEA|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 | Back alignment and structure |
| >pdb|1CKC|A Chain A, T43a Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GF9|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1B5X|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 | Back alignment and structure |
| >pdb|1B7O|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 | Back alignment and structure |
| >pdb|1OUH|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V74a Mutant Length = 130 | Back alignment and structure |
| >pdb|1EQE|A Chain A, Crystal Structures Of Salt Bridge Mutants Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GB0|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GE0|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 | Back alignment and structure |
| >pdb|1GFR|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GB6|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GAY|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|133L|A Chain A, Role Of Arg 115 In The Catalytic Action Of Human Lysozyme. X-Ray Structure Of His 115 And Glu 115 Mutants Length = 130 | Back alignment and structure |
| >pdb|1EQ5|A Chain A, Crystal Structures Of Salt Bridge Mutants Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GBY|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1B7Q|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 | Back alignment and structure |
| >pdb|1GB7|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GB9|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1LZS|A Chain A, Structural Changes Of The Active Site Cleft And Different Saccharide Binding Modes In Human Lysozyme Co-Crystallized With Hexa-N-Acetyl- Chitohexaose At Ph 4.0 Length = 130 | Back alignment and structure |
| >pdb|1OUF|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V130a Mutant Length = 130 | Back alignment and structure |
| >pdb|1OUE|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V125a Mutant Length = 130 | Back alignment and structure |
| >pdb|1GB8|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GFK|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1LYY|A Chain A, Amyloidogenic Variant (Asp67his) Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1IP7|A Chain A, G129a Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1CKH|A Chain A, T70v Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1CKG|A Chain A, T52v Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|134L|A Chain A, Role Of Arg 115 In The Catalytic Action Of Human Lysozyme. X-Ray Structure Of His 115 And Glu 115 Mutants Length = 130 | Back alignment and structure |
| >pdb|1CKD|A Chain A, T43v Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GFH|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1B7S|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 | Back alignment and structure |
| >pdb|1WQP|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GFT|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1GB3|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1WQN|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GAZ|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1LHL|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 | Back alignment and structure |
| >pdb|1B5W|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 | Back alignment and structure |
| >pdb|1GBW|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1WQO|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GBZ|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1YAM|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 | Back alignment and structure |
| >pdb|1GBX|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 | Back alignment and structure |
| >pdb|1W08|A Chain A, Structure Of T70n Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1IP4|A Chain A, G72a Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1IP1|A Chain A, G37a Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2HEB|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 | Back alignment and structure |
| >pdb|1GDW|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 | Back alignment and structure |
| >pdb|1YAO|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 | Back alignment and structure |
| >pdb|1YAP|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 | Back alignment and structure |
| >pdb|1YAN|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 | Back alignment and structure |
| >pdb|1YAQ|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 | Back alignment and structure |
| >pdb|1GF5|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1B5Y|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 | Back alignment and structure |
| >pdb|1B5V|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 | Back alignment and structure |
| >pdb|1C43|A Chain A, Mutant Human Lysozyme With Foreign N-Terminal Residues Length = 130 | Back alignment and structure |
| >pdb|1B5Z|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 | Back alignment and structure |
| >pdb|1CJ9|A Chain A, T40v Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1C45|A Chain A, Mutant Human Lysozyme With Foreign N-Terminal Residues Length = 130 | Back alignment and structure |
| >pdb|1JKC|A Chain A, Human Lysozyme Mutant With Trp 109 Replaced By Phe Length = 130 | Back alignment and structure |
| >pdb|1WQQ|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2MEE|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2MEB|A Chain A, Changes In Conformational Stability Of A Series Of Mutant Human Lysozymes At Constant Positions Length = 130 | Back alignment and structure |
| >pdb|2MEF|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2MEC|A Chain A, Changes In Conformational Stability Of A Series Of Mutant Human Lysozymes At Constant Positions Length = 130 | Back alignment and structure |
| >pdb|1GF0|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GEZ|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1LZ5|A Chain A, Structural And Functional Analyses Of The Arg-Gly-Asp Sequence Introduced Into Human Lysozyme Length = 134 | Back alignment and structure |
| >pdb|1EQ4|A Chain A, Crystal Structures Of Salt Bridge Mutants Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GE3|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 | Back alignment and structure |
| >pdb|1GE4|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 | Back alignment and structure |
| >pdb|1JKA|A Chain A, Human Lysozyme Mutant With Glu 35 Replaced By Asp Length = 130 | Back alignment and structure |
| >pdb|1TCY|A Chain A, Dissection Of The Functional Role Of Structural Elements Of Tyrosine-63 In The Catalytic Action Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1WQM|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GF6|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1IP5|A Chain A, G105a Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1OUJ|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V99a Mutant Length = 130 | Back alignment and structure |
| >pdb|1OUI|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V93a Mutant Length = 130 | Back alignment and structure |
| >pdb|1OUD|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V121a Mutant Length = 130 | Back alignment and structure |
| >pdb|1GF4|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2MEA|A Chain A, Changes In Conformational Stability Of A Series Of Mutant Human Lysozymes At Constant Positions Length = 130 | Back alignment and structure |
| >pdb|2MED|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1TDY|A Chain A, Dissection Of The Functional Role Of Structural Elements Of Tyrosine-63 In The Catalytic Action Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1LAA|A Chain A, X-Ray Structure Of Glu 53 Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1DI5|A Chain A, Role Of Amino Acid Residues At Turns In The Conformational Stability And Folding Of Human Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1B7L|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 | Back alignment and structure |
| >pdb|2MEH|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1LOZ|A Chain A, Amyloidogenic Variant (I56t) Variant Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GEV|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2HEC|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 | Back alignment and structure |
| >pdb|2HEF|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 | Back alignment and structure |
| >pdb|2HED|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 | Back alignment and structure |
| >pdb|1IP2|A Chain A, G48a Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2MEI|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1JKB|A Chain A, Human Lysozyme Mutant With Glu 35 Replaced By Ala Length = 130 | Back alignment and structure |
| >pdb|1GE1|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 | Back alignment and structure |
| >pdb|1BB4|A Chain A, Human Lysozyme Double Mutant A96l, W109h Length = 130 | Back alignment and structure |
| >pdb|1D6P|A Chain A, Human Lysozyme L63 Mutant Labelled With 2',3'-Epoxypropyl N,N'- Diacetylchitobiose Length = 130 | Back alignment and structure |
| >pdb|1B7R|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 | Back alignment and structure |
| >pdb|2MEG|A Chain A, Changes In Conformational Stability Of A Series Of Mutant Human Lysozymes At Constant Positions Length = 130 | Back alignment and structure |
| >pdb|1LZ6|A Chain A, Structural And Functional Analyses Of The Arg-Gly-Asp Sequence Introduced Into Human Lysozyme Length = 138 | Back alignment and structure |
| >pdb|1LMT|A Chain A, Structure Of A Conformationally Constrained Arg-Gly-Asp Sequence Inserted Into Human Lysozyme Length = 136 | Back alignment and structure |
| >pdb|208L|A Chain A, Mutant Human Lysozyme C77a Length = 130 | Back alignment and structure |
| >pdb|1LHK|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 | Back alignment and structure |
| >pdb|1B7N|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 | Back alignment and structure |
| >pdb|1JKD|A Chain A, Human Lysozyme Mutant With Trp 109 Replaced By Ala Length = 130 | Back alignment and structure |
| >pdb|2HEE|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 | Back alignment and structure |
| >pdb|1TAY|A Chain A, Dissection Of The Functional Role Of Structural Elements Of Tyrosine-63 In The Catalytic Action Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GE2|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 | Back alignment and structure |
| >pdb|1B7P|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 | Back alignment and structure |
| >pdb|2BQH|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1GHL|A Chain A, The Three-Dimensional Structure Of Pheasant And Guinea-Fowl Egg Lysozymes Length = 130 | Back alignment and structure |
| >pdb|2BQL|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1DI4|A Chain A, Role Of Amino Acid Residues At Turns In The Conformational Stability And Folding Of Human Lysozyme Length = 128 | Back alignment and structure |
| >pdb|2BQM|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1LHM|A Chain A, The Crystal Structure Of A Mutant Lysozyme C77(Slash)95a With Increased Secretion Efficiency In Yeast Length = 130 | Back alignment and structure |
| >pdb|2BQK|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2BQJ|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1IOR|A Chain A, Stabilization Of Hen Egg White Lysozyme By A Cavity-Filling Mutation Length = 129 | Back alignment and structure |
| >pdb|2BQB|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2BQD|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2BQE|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2BQC|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1LZD|A Chain A, Dissection Of Protein-Carbohydrate Interactions In Mutant Hen Egg-White Lysozyme Complexes And Their Hydrolytic Activity Length = 129 | Back alignment and structure |
| >pdb|2BQI|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1HER|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1IOQ|A Chain A, Stabilization Of Hen Egg White Lysozyme By A Cavity-Filling Mutation Length = 129 | Back alignment and structure |
| >pdb|1NBY|C Chain C, Crystal Structure Of Hyhel-63 Complexed With Hel Mutant K96a Length = 129 | Back alignment and structure |
| >pdb|1IOT|A Chain A, Stabilization Of Hen Egg White Lysozyme By A Cavity-Filling Mutation Length = 129 | Back alignment and structure |
| >pdb|1QSW|A Chain A, Crystal Structure Analysis Of A Human Lysozyme Mutant W64c C65a Length = 130 | Back alignment and structure |
| >pdb|1HEQ|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1IX0|A Chain A, I59a-3ss Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1FLU|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 | Back alignment and structure |
| >pdb|132L|A Chain A, Structural Consequences Of Reductive Methylation Of Lysine Residues In Hen Egg White Lysozyme: An X-Ray Analysis At 1.8 Angstroms Resolution Length = 129 | Back alignment and structure |
| >pdb|1A2Y|C Chain C, Hen Egg White Lysozyme, D18a Mutant, In Complex With Mouse Monoclonal Antibody D1.3 Length = 129 | Back alignment and structure |
| >pdb|1FLW|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 | Back alignment and structure |
| >pdb|1BQL|Y Chain Y, Structure Of An Anti-Hel Fab Fragment Complexed With Bobwhite Quail Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1IR7|A Chain A, Im Mutant Of Lysozyme Length = 129 | Back alignment and structure |
| >pdb|2IFF|Y Chain Y, Structure Of An Antibody-Lysozyme Complex: Effect Of A Conservative Mutation Length = 129 | Back alignment and structure |
| >pdb|1KXX|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 | Back alignment and structure |
| >pdb|1KXW|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 | Back alignment and structure |
| >pdb|1UIA|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 127 | Back alignment and structure |
| >pdb|1HEP|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1LZG|A Chain A, Dissection Of Protein-Carbohydrate Interactions In Mutant Hen Egg- White Lysozyme Complexes And Their Hydrolytic Activity Length = 129 | Back alignment and structure |
| >pdb|1JHL|A Chain A, Three-Dimensional Structure Of A Heteroclitic Antigen- Antibody Cross-Reaction Complex Length = 129 | Back alignment and structure |
| >pdb|1FLQ|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 | Back alignment and structure |
| >pdb|1FBI|X Chain X, Crystal Structure Of A Cross-Reaction Complex Between Fab F9.13.7 And Guinea-Fowl Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1FDL|Y Chain Y, Crystallographic Refinement Of The Three-Dimensional Structure Of The Fab D1.3-Lysozyme Complex At 2.5- Angstroms Resolution Length = 129 | Back alignment and structure |
| >pdb|1UIC|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 | Back alignment and structure |
| >pdb|1KXY|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 | Back alignment and structure |
| >pdb|1HEM|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1AT6|A Chain A, Hen Egg White Lysozyme With A Isoaspartate Residue Length = 129 | Back alignment and structure |
| >pdb|1V7S|A Chain A, Triclinic Hen Lysozyme Crystallized At 313k From A D2o Solution Length = 129 | Back alignment and structure |
| >pdb|1UID|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 | Back alignment and structure |
| >pdb|1LSG|A Chain A, Three-Dimensional Structure Of The Platelet Integrin Recognition Segment Of The Fibrinogen Gamma Chain Obtained By Carrier Protein-Driven Crystallization Length = 144 | Back alignment and structure |
| >pdb|1LSN|A Chain A, Thermal Stability Determinants Of Chicken Egg-White Lysozyme Core Mutants: Hydrophobicity, Packing Volume And Conserved Buried Water Molecules Length = 129 | Back alignment and structure |
| >pdb|1UIF|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 | Back alignment and structure |
| >pdb|1UIE|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 | Back alignment and structure |
| >pdb|3QY4|A Chain A, Crystallization And In Situ Data Collection Of Lysozyme Using The Crystal Former Length = 129 | Back alignment and structure |
| >pdb|1HEO|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1IVM|A Chain A, Solution Structure Of Mouse Lysozyme M Length = 130 | Back alignment and structure |
| >pdb|1IO5|A Chain A, Hydrogen And Hydration Of Hen Egg-White Lysozyme Determined By Neutron Diffraction Length = 129 | Back alignment and structure |
| >pdb|1HEN|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1IOS|A Chain A, Stabilization Of Hen Egg White Lysozyme By A Cavity-Filling Mutation Length = 129 | Back alignment and structure |
| >pdb|1IR9|A Chain A, Im Mutant Of Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1IR8|A Chain A, Im Mutant Of Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1LSM|A Chain A, Thermal Stability Determinants Of Chicken Egg-White Lysozyme Core Mutants: Hydrophobicity, Packing Volume And Conserved Buried Water Molecules Length = 129 | Back alignment and structure |
| >pdb|1NDG|C Chain C, Crystal Structure Of Fab Fragment Of Antibody Hyhel-8 Complexed With Its Antigen Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1H6M|A Chain A, Covalent Glycosyl-Enzyme Intermediate Of Hen Egg White Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1DZB|X Chain X, Crystal Structure Of Phage Library-Derived Single-Chain Fv Fragment 1f9 In Complex With Turkey Egg-White Lysozyme Length = 129 | Back alignment and structure |
| >pdb|1HHL|A Chain A, The Three-Dimensional Structure Of Pheasant And Guinea-Fowl Egg Lysozymes Length = 129 | Back alignment and structure |
| >pdb|3A3Q|A Chain A, Structure Of N59d Hen Egg-White Lysozyme In Complex With (Glcnac)3 Length = 129 | Back alignment and structure |
| >pdb|3OJP|A Chain A, D52n Mutant Of Hen Egg White Lysozyme (Hewl) Length = 129 | Back alignment and structure |
| >pdb|1FLY|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 | Back alignment and structure |
| >pdb|1NBZ|C Chain C, Crystal Structure Of Hyhel-63 Complexed With Hel Mutant K97a Length = 129 | Back alignment and structure |
| >pdb|1LZ2|A Chain A, Crystallographic Study Of Turkey Egg-White Lysozyme And Its Complex With A Disaccharide Length = 129 | Back alignment and structure |
| >pdb|1FN5|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 | Back alignment and structure |
| >pdb|3OK0|A Chain A, E35a Mutant Of Hen Egg White Lysozyme (Hewl) Length = 129 | Back alignment and structure |
| >pdb|1AT5|A Chain A, Hen Egg White Lysozyme With A Succinimide Residue Length = 129 | Back alignment and structure |
| >pdb|1BB6|A Chain A, Lysozyme Complex With 4-Methyl-Umbelliferyl Chitotriose Length = 129 | Back alignment and structure |
| >pdb|2Z2F|A Chain A, X-Ray Crystal Structure Of Bovine Stomach Lysozyme Length = 129 | Back alignment and structure |
| >pdb|2BQN|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2IHL|A Chain A, Lysozyme (e.c.3.2.1.17) (japanese Quail) Length = 129 | Back alignment and structure |
| >pdb|2GV0|A Chain A, The Structure Of The Orthorhombic Form Of Soft-Shelled Turtle Lysozyme At 1.9 Angstroms Resolution Length = 131 | Back alignment and structure |
| >pdb|2BQO|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|2BQG|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1HML|A Chain A, Alpha_lactalbumin Possesses A Distinct Zinc Binding Site Length = 142 | Back alignment and structure |
| >pdb|2BQF|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 | Back alignment and structure |
| >pdb|1HFZ|A Chain A, Alpha-Lactalbumin Length = 124 | Back alignment and structure |
| >pdb|1F6R|A Chain A, Crystal Structure Of Apo-Bovine Alpha-Lactalbumin Length = 123 | Back alignment and structure |
| >pdb|1FKV|A Chain A, Recombinant Goat Alpha-Lactalbumin T29i Length = 124 | Back alignment and structure |
| >pdb|1FKQ|A Chain A, Recombinant Goat Alpha-Lactalbumin T29v Length = 124 | Back alignment and structure |
| >pdb|2GOI|A Chain A, Crystal Structure Of Mouse Sperm C-Type Lysozyme-Like Protein 1 Length = 138 | Back alignment and structure |
| >pdb|1A4V|A Chain A, Alpha-Lactalbumin Length = 123 | Back alignment and structure |
| >pdb|3B0I|A Chain A, Crystal Structure Of Recombinant Human Alpha Lactalbumin Length = 124 | Back alignment and structure |
| >pdb|1HMK|A Chain A, Recombinant Goat Alpha-Lactalbumin Length = 124 | Back alignment and structure |
| >pdb|1HFY|A Chain A, Alpha-Lactalbumin Length = 123 | Back alignment and structure |
| >pdb|3B0K|A Chain A, Crystal Structure Of Alpha-Lactalbumin Length = 123 | Back alignment and structure |
| >pdb|1ALC|A Chain A, Refined Structure Of Baboon Alpha-Lactalbumin At 1.7 Angstroms Resolution. Comparison With C-Type Lysozyme Length = 123 | Back alignment and structure |
| >pdb|1B9O|A Chain A, Human Alpha-Lactalbumin, Low Temperature Form Length = 123 | Back alignment and structure |
| >pdb|3B0O|A Chain A, Crystal Structure Of Alpha-Lactalbumin Length = 123 | Back alignment and structure |
| >pdb|1JUG|A Chain A, Lysozyme From Echidna Milk (Tachyglossus Aculeatus) Length = 125 | Back alignment and structure |
| >pdb|3ZVQ|A Chain A, Crystal Structure Of Proteolyzed Lysozyme Length = 70 | Back alignment and structure |
| >pdb|2VJ3|A Chain A, Human Notch-1 Egfs 11-13 Length = 135 | Back alignment and structure |
| >pdb|1TOZ|A Chain A, Nmr Structure Of The Human Notch-1 Ligand Binding Region Length = 116 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 769 | |||
| 1iiz_A | 120 | Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCO | 2e-31 | |
| 1iiz_A | 120 | Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCO | 1e-15 | |
| 2fbd_A | 122 | Lysozyme 1; digestive lysozime, hydrolase; HET: PE | 2e-30 | |
| 2fbd_A | 122 | Lysozyme 1; digestive lysozime, hydrolase; HET: PE | 8e-15 | |
| 1qqy_A | 130 | Lysozyme C; APO-type protein, calcium binding lyso | 3e-28 | |
| 1qqy_A | 130 | Lysozyme C; APO-type protein, calcium binding lyso | 4e-14 | |
| 1hml_A | 142 | Alpha-lactalbumin; calcium-binding protein; 1.70A | 5e-28 | |
| 1hml_A | 142 | Alpha-lactalbumin; calcium-binding protein; 1.70A | 3e-12 | |
| 3b72_A | 147 | Lysozyme C; hen egg-white lysozyme, protein-SDS co | 9e-28 | |
| 3b72_A | 147 | Lysozyme C; hen egg-white lysozyme, protein-SDS co | 8e-14 | |
| 2gv0_A | 131 | Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} | 2e-27 | |
| 2gv0_A | 131 | Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} | 2e-13 | |
| 2goi_A | 138 | Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1 | 2e-27 | |
| 2goi_A | 138 | Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1 | 2e-14 | |
| 1yro_A | 123 | Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL com | 2e-27 | |
| 1yro_A | 123 | Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL com | 1e-13 | |
| 2nwd_X | 130 | Lysozyme C; native chemical ligation, chemical pro | 8e-27 | |
| 2nwd_X | 130 | Lysozyme C; native chemical ligation, chemical pro | 4e-13 | |
| 2z2f_A | 129 | Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylm | 1e-26 | |
| 2z2f_A | 129 | Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylm | 8e-13 | |
| 1b9o_A | 123 | Protein (alpha-lactalbumin); calcium-binding prote | 1e-26 | |
| 1b9o_A | 123 | Protein (alpha-lactalbumin); calcium-binding prote | 6e-13 | |
| 1jug_A | 125 | Lysozyme; calcium-binding; 1.90A {Tachyglossus acu | 1e-26 | |
| 1jug_A | 125 | Lysozyme; calcium-binding; 1.90A {Tachyglossus acu | 8e-14 | |
| 1lsg_A | 144 | Hen egg white lysozyme; fibrinogen, hybrid protein | 3e-26 | |
| 1lsg_A | 144 | Hen egg white lysozyme; fibrinogen, hybrid protein | 5e-14 | |
| 2vb1_A | 129 | Lysozyme C; antimicrobial, triclinic HEWL, atomic | 5e-26 | |
| 2vb1_A | 129 | Lysozyme C; antimicrobial, triclinic HEWL, atomic | 9e-14 | |
| 1lmq_A | 129 | Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1. | 8e-26 | |
| 1lmq_A | 129 | Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1. | 6e-13 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 8e-14 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 8e-09 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 3e-13 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 3e-10 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 3e-12 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 4e-10 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 2e-06 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 6e-05 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 7e-04 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 1e-11 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 2e-11 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 5e-09 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 8e-11 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 9e-07 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 1e-06 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 4e-09 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 2e-08 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 2e-08 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 2e-08 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 2e-04 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 2e-08 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 3e-08 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 5e-07 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 3e-04 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 6e-07 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 9e-06 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 2e-05 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 3e-04 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 2e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-06 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 4e-06 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 1e-05 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 5e-06 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 2e-05 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 3e-05 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 1e-04 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 7e-04 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 2e-04 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 5e-04 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 4e-04 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 4e-04 | |
| 1b9w_A | 95 | Protein (merozoite surface protein 1); MSP-1, cand | 4e-04 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 5e-04 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 5e-04 |
| >1iiz_A Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCOP: d.2.1.2 PDB: 1gd6_A Length = 120 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 46/118 (38%), Positives = 64/118 (54%), Gaps = 8/118 (6%)
Query: 279 KRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDK 338
KRF C L L +Q G + WVC+ ES R ++ + N NGSRD+G+FQINDK
Sbjct: 1 KRFTRCGLVNELRKQ-GFDENLMRDWVCLVENESARYTDKIANVNKNGSRDYGLFQINDK 59
Query: 339 YWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTY-HYCN 395
YWC+ GK+C+ CS ++IT C KI+ + F AWS + ++CN
Sbjct: 60 YWCSKGSTPGKDCNVTCSQLLTDDITVASTCAKKIYKR------TKFDAWSGWDNHCN 111
|
| >1iiz_A Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCOP: d.2.1.2 PDB: 1gd6_A Length = 120 | Back alignment and structure |
|---|
| >2fbd_A Lysozyme 1; digestive lysozime, hydrolase; HET: PEG; 1.90A {Musca domestica} PDB: 2h5z_A* 3cb7_A Length = 122 | Back alignment and structure |
|---|
| >2fbd_A Lysozyme 1; digestive lysozime, hydrolase; HET: PEG; 1.90A {Musca domestica} PDB: 2h5z_A* 3cb7_A Length = 122 | Back alignment and structure |
|---|
| >1qqy_A Lysozyme C; APO-type protein, calcium binding lysozyme, enzyme, hydrolase; 1.85A {Canis lupus familiaris} SCOP: d.2.1.2 PDB: 1el1_A 1i56_A 2cwi_A 2z2e_A 2eql_A Length = 130 | Back alignment and structure |
|---|
| >1qqy_A Lysozyme C; APO-type protein, calcium binding lysozyme, enzyme, hydrolase; 1.85A {Canis lupus familiaris} SCOP: d.2.1.2 PDB: 1el1_A 1i56_A 2cwi_A 2z2e_A 2eql_A Length = 130 | Back alignment and structure |
|---|
| >1hml_A Alpha-lactalbumin; calcium-binding protein; 1.70A {Homo sapiens} SCOP: d.2.1.2 Length = 142 | Back alignment and structure |
|---|
| >1hml_A Alpha-lactalbumin; calcium-binding protein; 1.70A {Homo sapiens} SCOP: d.2.1.2 Length = 142 | Back alignment and structure |
|---|
| >3b72_A Lysozyme C; hen egg-white lysozyme, protein-SDS complex, MPD, allergen, antimicrobial, bacteriolytic enzyme glycosidase, hydrolase; 1.50A {Gallus gallus} SCOP: d.2.1.2 PDB: 3b6l_A 1lsy_A 1lsz_A* Length = 147 | Back alignment and structure |
|---|
| >3b72_A Lysozyme C; hen egg-white lysozyme, protein-SDS complex, MPD, allergen, antimicrobial, bacteriolytic enzyme glycosidase, hydrolase; 1.50A {Gallus gallus} SCOP: d.2.1.2 PDB: 3b6l_A 1lsy_A 1lsz_A* Length = 147 | Back alignment and structure |
|---|
| >2gv0_A Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} Length = 131 | Back alignment and structure |
|---|
| >2gv0_A Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} Length = 131 | Back alignment and structure |
|---|
| >2goi_A Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1, sperm C-type lysozyme-like protein 1, acrosomal sperm protein, sperm-egg binding, fertilization; 2.30A {Mus musculus} Length = 138 | Back alignment and structure |
|---|
| >2goi_A Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1, sperm C-type lysozyme-like protein 1, acrosomal sperm protein, sperm-egg binding, fertilization; 2.30A {Mus musculus} Length = 138 | Back alignment and structure |
|---|
| >1yro_A Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL complex, transferase activator/transferase complex; HET: GDU UDP MES PG4; 1.90A {Mus musculus} SCOP: d.2.1.2 PDB: 1nhe_A* 1nkh_A* 1nmm_A* 1nqi_A* 1nwg_A* 1o23_A* 1oqm_A* 1pzy_A* 1nf5_A* 2fyc_A* 2fyd_A* Length = 123 | Back alignment and structure |
|---|
| >1yro_A Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL complex, transferase activator/transferase complex; HET: GDU UDP MES PG4; 1.90A {Mus musculus} SCOP: d.2.1.2 PDB: 1nhe_A* 1nkh_A* 1nmm_A* 1nqi_A* 1nwg_A* 1o23_A* 1oqm_A* 1pzy_A* 1nf5_A* 2fyc_A* 2fyd_A* Length = 123 | Back alignment and structure |
|---|
| >2nwd_X Lysozyme C; native chemical ligation, chemical protein synthesis, convergent synthesis, hydrolase; 1.04A {Synthetic} SCOP: d.2.1.2 PDB: 1iwu_A 1iwv_A 1iww_A 1iwx_A 1iwy_A 1iwz_A 1iy3_A 1iy4_A 1iwt_A 1jwr_A 1lz1_A 1lzr_A* 1lzs_A* 1op9_B 1re2_A* 1rem_A* 1rex_A 1rey_A* 1rez_A* 1jsf_A ... Length = 130 | Back alignment and structure |
|---|
| >2nwd_X Lysozyme C; native chemical ligation, chemical protein synthesis, convergent synthesis, hydrolase; 1.04A {Synthetic} SCOP: d.2.1.2 PDB: 1iwu_A 1iwv_A 1iww_A 1iwx_A 1iwy_A 1iwz_A 1iy3_A 1iy4_A 1iwt_A 1jwr_A 1lz1_A 1lzr_A* 1lzs_A* 1op9_B 1re2_A* 1rem_A* 1rex_A 1rey_A* 1rez_A* 1jsf_A ... Length = 130 | Back alignment and structure |
|---|
| >2z2f_A Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylmuramidase C, bacteriolytic enzyme, hydrolase; 1.50A {Bos taurus} Length = 129 | Back alignment and structure |
|---|
| >2z2f_A Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylmuramidase C, bacteriolytic enzyme, hydrolase; 1.50A {Bos taurus} Length = 129 | Back alignment and structure |
|---|
| >1b9o_A Protein (alpha-lactalbumin); calcium-binding protein, high resolution; 1.15A {Homo sapiens} SCOP: d.2.1.2 PDB: 1a4v_A 1alc_A 1hmk_A 1hfy_A 1f6r_A 1f6s_A 2g4n_A 1fkq_A 1fkv_A 1hfz_A 1hfx_A Length = 123 | Back alignment and structure |
|---|
| >1b9o_A Protein (alpha-lactalbumin); calcium-binding protein, high resolution; 1.15A {Homo sapiens} SCOP: d.2.1.2 PDB: 1a4v_A 1alc_A 1hmk_A 1hfy_A 1f6r_A 1f6s_A 2g4n_A 1fkq_A 1fkv_A 1hfz_A 1hfx_A Length = 123 | Back alignment and structure |
|---|
| >1jug_A Lysozyme; calcium-binding; 1.90A {Tachyglossus aculeatus} SCOP: d.2.1.2 Length = 125 | Back alignment and structure |
|---|
| >1jug_A Lysozyme; calcium-binding; 1.90A {Tachyglossus aculeatus} SCOP: d.2.1.2 Length = 125 | Back alignment and structure |
|---|
| >1lsg_A Hen egg white lysozyme; fibrinogen, hybrid protein; 2.40A {Gallus gallus} SCOP: d.2.1.2 Length = 144 | Back alignment and structure |
|---|
| >1lsg_A Hen egg white lysozyme; fibrinogen, hybrid protein; 2.40A {Gallus gallus} SCOP: d.2.1.2 Length = 144 | Back alignment and structure |
|---|
| >2vb1_A Lysozyme C; antimicrobial, triclinic HEWL, atomic resolution, allergen, hydrolase, glycosidase, bacteriolytic enzyme; HET: EDO; 0.65A {Gallus gallus} SCOP: d.2.1.2 PDB: 194l_A 1aki_A 1azf_A 1b0d_A* 1b2k_A 1bgi_A 1bhz_A 1bvk_C 1bvx_A 1bwh_A 1bwi_A 1bwj_A 1c08_C 1c10_A 1dpw_A 1dpx_A 1dqj_C 1e8l_A 1f0w_A 1f10_A ... Length = 129 | Back alignment and structure |
|---|
| >2vb1_A Lysozyme C; antimicrobial, triclinic HEWL, atomic resolution, allergen, hydrolase, glycosidase, bacteriolytic enzyme; HET: EDO; 0.65A {Gallus gallus} SCOP: d.2.1.2 PDB: 194l_A 1aki_A 1azf_A 1b0d_A* 1b2k_A 1bgi_A 1bhz_A 1bvk_C 1bvx_A 1bwh_A 1bwi_A 1bwj_A 1c08_C 1c10_A 1dpw_A 1dpx_A 1dqj_C 1e8l_A 1f0w_A 1f10_A ... Length = 129 | Back alignment and structure |
|---|
| >1lmq_A Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1.60A {Oncorhynchus mykiss} SCOP: d.2.1.2 PDB: 1bb7_A* 1lmc_A* 1bb6_A 1lmo_A* 1lmp_A* 1lmn_A* Length = 129 | Back alignment and structure |
|---|
| >1lmq_A Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1.60A {Oncorhynchus mykiss} SCOP: d.2.1.2 PDB: 1bb7_A* 1lmc_A* 1bb6_A 1lmo_A* 1lmp_A* 1lmn_A* Length = 129 | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Length = 142 | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Length = 142 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Length = 91 | Back alignment and structure |
|---|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Length = 91 | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114 | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114 | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 | Back alignment and structure |
|---|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A Length = 39 | Back alignment and structure |
|---|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A Length = 39 | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 426 | Back alignment and structure |
|---|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
| >1b9w_A Protein (merozoite surface protein 1); MSP-1, candidate malaria vaccine, surface antigen; 1.80A {Plasmodium cynomolgi} SCOP: g.3.11.4 g.3.11.4 PDB: 2npr_A Length = 95 | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143 | Back alignment and structure |
|---|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Length = 99 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 769 | |||
| 1hml_A | 142 | Alpha-lactalbumin; calcium-binding protein; 1.70A | 100.0 | |
| 1iiz_A | 120 | Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCO | 100.0 | |
| 1b9o_A | 123 | Protein (alpha-lactalbumin); calcium-binding prote | 100.0 | |
| 1yro_A | 123 | Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL com | 100.0 | |
| 1qqy_A | 130 | Lysozyme C; APO-type protein, calcium binding lyso | 100.0 | |
| 2goi_A | 138 | Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1 | 100.0 | |
| 2gv0_A | 131 | Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} | 100.0 | |
| 2nwd_X | 130 | Lysozyme C; native chemical ligation, chemical pro | 100.0 | |
| 2z2f_A | 129 | Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylm | 100.0 | |
| 2fbd_A | 122 | Lysozyme 1; digestive lysozime, hydrolase; HET: PE | 100.0 | |
| 3b72_A | 147 | Lysozyme C; hen egg-white lysozyme, protein-SDS co | 100.0 | |
| 1lsg_A | 144 | Hen egg white lysozyme; fibrinogen, hybrid protein | 100.0 | |
| 2vb1_A | 129 | Lysozyme C; antimicrobial, triclinic HEWL, atomic | 100.0 | |
| 1jug_A | 125 | Lysozyme; calcium-binding; 1.90A {Tachyglossus acu | 100.0 | |
| 1lmq_A | 129 | Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1. | 100.0 | |
| 1iiz_A | 120 | Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCO | 99.94 | |
| 1qqy_A | 130 | Lysozyme C; APO-type protein, calcium binding lyso | 99.94 | |
| 2goi_A | 138 | Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1 | 99.93 | |
| 2gv0_A | 131 | Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} | 99.93 | |
| 2nwd_X | 130 | Lysozyme C; native chemical ligation, chemical pro | 99.93 | |
| 1b9o_A | 123 | Protein (alpha-lactalbumin); calcium-binding prote | 99.93 | |
| 2vb1_A | 129 | Lysozyme C; antimicrobial, triclinic HEWL, atomic | 99.93 | |
| 1yro_A | 123 | Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL com | 99.93 | |
| 2z2f_A | 129 | Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylm | 99.93 | |
| 1hml_A | 142 | Alpha-lactalbumin; calcium-binding protein; 1.70A | 99.92 | |
| 1lsg_A | 144 | Hen egg white lysozyme; fibrinogen, hybrid protein | 99.92 | |
| 2fbd_A | 122 | Lysozyme 1; digestive lysozime, hydrolase; HET: PE | 99.92 | |
| 3b72_A | 147 | Lysozyme C; hen egg-white lysozyme, protein-SDS co | 99.92 | |
| 1lmq_A | 129 | Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1. | 99.91 | |
| 1jug_A | 125 | Lysozyme; calcium-binding; 1.90A {Tachyglossus acu | 99.91 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 99.8 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 99.78 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 99.76 | |
| 4fbr_A | 267 | Lectin, myxobacterial hemagglutinin; beta-barrel, | 99.72 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 99.69 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 99.67 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 99.63 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 99.62 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 99.58 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 99.54 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 99.53 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 99.53 | |
| 4fbr_A | 267 | Lectin, myxobacterial hemagglutinin; beta-barrel, | 99.5 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 99.5 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 99.49 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 99.49 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 99.47 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 99.46 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 99.4 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 99.39 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 99.27 | |
| 2w86_A | 147 | Fibrillin-1, fibrillin1; phosphoprotein, EGF-like | 99.24 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 99.21 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 99.16 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 99.16 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 99.15 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 99.14 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 99.04 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 99.0 | |
| 2w86_A | 147 | Fibrillin-1, fibrillin1; phosphoprotein, EGF-like | 98.99 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 98.98 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 98.97 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 98.91 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 98.91 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 98.89 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 98.89 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 98.87 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 98.86 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 98.86 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 98.84 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 98.83 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 98.82 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 98.81 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 98.79 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 98.77 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 98.73 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 98.71 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 98.7 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 98.68 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 98.56 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 98.52 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 98.44 | |
| 1n7d_A | 699 | LDL receptor, low-density lipoprotein receptor; fa | 98.44 | |
| 2p28_B | 217 | Integrin beta-2; hybrid domain, PSI domain, I-EGF | 98.41 | |
| 3m0c_C | 791 | LDL receptor, low-density lipoprotein receptor; pr | 98.35 | |
| 1klo_A | 162 | Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: | 98.34 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 98.33 | |
| 1n7d_A | 699 | LDL receptor, low-density lipoprotein receptor; fa | 98.31 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 98.3 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 98.28 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 98.25 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 98.2 | |
| 3m0c_C | 791 | LDL receptor, low-density lipoprotein receptor; pr | 98.2 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 98.18 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 98.14 | |
| 2p28_B | 217 | Integrin beta-2; hybrid domain, PSI domain, I-EGF | 98.12 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 98.12 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 98.11 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 97.99 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 97.99 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 97.94 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 97.9 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 97.85 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 97.79 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 97.78 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 97.72 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 97.72 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 97.58 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 97.56 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 97.52 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 97.4 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 97.29 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 97.23 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 97.14 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 97.01 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 96.83 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 96.52 | |
| 2fd6_A | 122 | Urokinase-type plasminogen activator; UPAR, ATF, A | 96.48 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 96.43 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 96.29 | |
| 1q4g_A | 553 | Prostaglandin G/H synthase 1; cyclooxygenase, non- | 96.27 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 96.26 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 96.21 | |
| 3nt1_A | 587 | Prostaglandin-endoperoxide synthase 2; prostagland | 96.13 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 96.0 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 95.99 | |
| 1q4g_A | 553 | Prostaglandin G/H synthase 1; cyclooxygenase, non- | 95.62 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 95.59 | |
| 3cfw_A | 164 | L-selectin; EGF, cell adhesion, EGF-like domain, g | 95.55 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 95.49 | |
| 2fd6_A | 122 | Urokinase-type plasminogen activator; UPAR, ATF, A | 95.46 | |
| 1kli_L | 69 | Factor VIIA; extrinsic coagulation pathway, serine | 95.37 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 95.33 | |
| 2kl7_A | 71 | Fibulin-4; secreted, calcium, disease mutation, di | 95.3 | |
| 3nt1_A | 587 | Prostaglandin-endoperoxide synthase 2; prostagland | 95.19 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 95.15 | |
| 1klo_A | 162 | Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: | 95.06 | |
| 3e50_C | 50 | Protransforming growth factor alpha; IDE, TGF-alph | 94.98 | |
| 2kl7_A | 71 | Fibulin-4; secreted, calcium, disease mutation, di | 94.97 | |
| 3cfw_A | 164 | L-selectin; EGF, cell adhesion, EGF-like domain, g | 94.81 | |
| 1g1t_A | 157 | E-selectin; EGF, adhesion molecule, SLEX, immune s | 94.6 | |
| 2i9a_A | 145 | Urokinase-type plasminogen activator; growth facto | 94.27 | |
| 1kli_L | 69 | Factor VIIA; extrinsic coagulation pathway, serine | 93.84 | |
| 3e50_C | 50 | Protransforming growth factor alpha; IDE, TGF-alph | 93.8 | |
| 1iox_A | 50 | Betacellulin; EGF-like fold, hormone/growth factor | 93.67 | |
| 2rnl_A | 50 | Amphiregulin; AR, colorectum cell-derived growth f | 93.66 | |
| 1g1t_A | 157 | E-selectin; EGF, adhesion molecule, SLEX, immune s | 93.52 | |
| 1kig_L | 51 | Factor XA; glycoprotein, serine protease, plasma, | 93.26 | |
| 1xdt_R | 79 | Hbegf, heparin-binding epidermal growth factor; co | 93.13 | |
| 3asi_A | 410 | Neurexin-1-alpha; beta-sandwich, cell adhesion, sy | 93.04 | |
| 2bz6_L | 53 | Blood coagulation factor VIIA; serine protease, en | 92.82 | |
| 1kig_L | 51 | Factor XA; glycoprotein, serine protease, plasma, | 92.62 | |
| 1xdt_R | 79 | Hbegf, heparin-binding epidermal growth factor; co | 92.22 | |
| 2bz6_L | 53 | Blood coagulation factor VIIA; serine protease, en | 91.92 | |
| 1iox_A | 50 | Betacellulin; EGF-like fold, hormone/growth factor | 91.9 | |
| 2ygo_A | 188 | WIF-1, WNT inhibitory factor 1; signaling protein, | 91.13 | |
| 2i9a_A | 145 | Urokinase-type plasminogen activator; growth facto | 90.76 | |
| 2rnl_A | 50 | Amphiregulin; AR, colorectum cell-derived growth f | 90.75 | |
| 1szb_A | 170 | Mannose binding lectin-associated serine protease- | 90.58 | |
| 3asi_A | 410 | Neurexin-1-alpha; beta-sandwich, cell adhesion, sy | 90.42 | |
| 1gbs_A | 185 | Australian black SWAN egg white lysozyme; hydrolas | 90.39 | |
| 2ygo_A | 188 | WIF-1, WNT inhibitory factor 1; signaling protein, | 89.6 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 89.07 | |
| 3qcw_A | 1245 | Neurexin-1-alpha; synaptic adhesion molecule, cell | 88.96 | |
| 3gxr_A | 187 | Goose-type lysozyme 1; atlantic COD, FISH lysozyme | 87.6 | |
| 3qcw_A | 1245 | Neurexin-1-alpha; synaptic adhesion molecule, cell | 87.58 | |
| 3t21_A | 206 | Endo-type membrane-bound lytic murein transglycos; | 87.19 | |
| 2e26_A | 725 | Reelin, reeler protein; signaling protein; HET: NA | 86.82 | |
| 2wph_E | 59 | Coagulation factor IXA light chain; serine proteas | 86.79 | |
| 1szb_A | 170 | Mannose binding lectin-associated serine protease- | 86.11 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 84.19 | |
| 4aqt_A | 375 | Laminin subunit gamma-1; cell adhesion; HET: NAG B | 83.22 | |
| 2wph_E | 59 | Coagulation factor IXA light chain; serine proteas | 82.81 | |
| 1nzi_A | 159 | Complement C1S component; calcium, innate immunity | 80.85 |
| >1hml_A Alpha-lactalbumin; calcium-binding protein; 1.70A {Homo sapiens} SCOP: d.2.1.2 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=362.63 Aligned_cols=119 Identities=32% Similarity=0.640 Sum_probs=110.7
Q ss_pred ccceeecchHHHHHHHHhcCCCCCCcccceEeeccccCCCcccccCCCCCCCceeeeeeeccccccCCCCCC--cccccc
Q psy9686 276 IEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPA--GKECHA 353 (769)
Q Consensus 276 ~~ak~~~rCela~~l~~~~g~~~~~l~~wvCla~~eS~~~t~a~~~~~~~gs~~yGifQIn~~~WC~~~~~~--~~~C~~ 353 (769)
++||+|+||||||+|+..+||++++|++|||||++||+|||+|+++ | |||+|||||||||+|||++++.+ +|.|+|
T Consensus 17 ~~ak~~~rCeLar~L~~~~g~~~~~l~~WvCiA~~ES~~nt~a~n~-n-dgS~dyGLFQINs~~WC~~~~~~~~~n~C~i 94 (142)
T 1hml_A 17 ILAKQFTKCELSQLLKDIDGYGGIALPELICTMFHTSGYDTQAIVE-N-NESTEYGLFQISNKLWCKSSQVPQSRNICDI 94 (142)
T ss_dssp ---CBCCHHHHHHHTGGGTTGGGCCHHHHHHHHHHHHTTBTTCEEE-C-SSCEEETTTTEETTTTSBCTTCTTCCCTTCS
T ss_pred hccceechhHHHHHHHhccCCChhHHHHHHHHHHHhcCCCccCeeC-C-CCCcceeeeeechhhhcCCCCCCcccccCCC
Confidence 6899999999999999767999999999999999999999999997 6 99999999999999999988653 699999
Q ss_pred ccccccCCChhHHHHHHHHHHhcccccccCcccccccCc-cccCCCCCcccc
Q psy9686 354 KCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YCNTNSKVSTYD 404 (769)
Q Consensus 354 ~C~~ll~~di~~~i~Cak~i~~~~~~~~~~G~~aW~~w~-~C~g~~~l~~~~ 404 (769)
+|++||||||+|||+|||+|+++ +||+||++|+ ||+| ||++|.
T Consensus 95 ~C~dLl~ddI~~~i~CAk~I~~~------~G~~aW~~w~~~C~g--~l~~w~ 138 (142)
T 1hml_A 95 SCDKFLDDDITDDIMCAKKILDI------KGIDYWLAHKALCTE--KLEQWL 138 (142)
T ss_dssp BGGGGSSSCCHHHHHHHHHHHHH------TCGGGSTHHHHHSSS--SCGGGC
T ss_pred CHHHHcCccHHHHHHHHHHHHHh------cCcchhHHHHHhCCC--CCcccc
Confidence 99999999999999999999998 6999999999 9999 799996
|
| >1iiz_A Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCOP: d.2.1.2 PDB: 1gd6_A | Back alignment and structure |
|---|
| >1b9o_A Protein (alpha-lactalbumin); calcium-binding protein, high resolution; 1.15A {Homo sapiens} SCOP: d.2.1.2 PDB: 1a4v_A 1alc_A 1hmk_A 1hfy_A 1f6r_A 1f6s_A 2g4n_A 1fkq_A 1fkv_A 1hfz_A 1hfx_A | Back alignment and structure |
|---|
| >1yro_A Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL complex, transferase activator/transferase complex; HET: GDU UDP MES PG4; 1.90A {Mus musculus} SCOP: d.2.1.2 PDB: 1nhe_A* 1nkh_A* 1nmm_A* 1nqi_A* 1nwg_A* 1o23_A* 1oqm_A* 1pzy_A* 1nf5_A* 2fyc_A* 2fyd_A* | Back alignment and structure |
|---|
| >1qqy_A Lysozyme C; APO-type protein, calcium binding lysozyme, enzyme, hydrolase; 1.85A {Canis lupus familiaris} SCOP: d.2.1.2 PDB: 1el1_A 1i56_A 2cwi_A 2z2e_A 2eql_A | Back alignment and structure |
|---|
| >2goi_A Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1, sperm C-type lysozyme-like protein 1, acrosomal sperm protein, sperm-egg binding, fertilization; 2.30A {Mus musculus} | Back alignment and structure |
|---|
| >2gv0_A Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} | Back alignment and structure |
|---|
| >2nwd_X Lysozyme C; native chemical ligation, chemical protein synthesis, convergent synthesis, hydrolase; 1.04A {Synthetic} SCOP: d.2.1.2 PDB: 1iwu_A 1iwv_A 1iww_A 1iwx_A 1iwy_A 1iwz_A 1iy3_A 1iy4_A 1iwt_A 1jwr_A 1lz1_A 1lzr_A* 1lzs_A* 1op9_B 1re2_A* 1rem_A* 1rex_A 1rey_A* 1rez_A* 1jsf_A ... | Back alignment and structure |
|---|
| >2z2f_A Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylmuramidase C, bacteriolytic enzyme, hydrolase; 1.50A {Bos taurus} | Back alignment and structure |
|---|
| >2fbd_A Lysozyme 1; digestive lysozime, hydrolase; HET: PEG; 1.90A {Musca domestica} PDB: 2h5z_A* 3cb7_A | Back alignment and structure |
|---|
| >3b72_A Lysozyme C; hen egg-white lysozyme, protein-SDS complex, MPD, allergen, antimicrobial, bacteriolytic enzyme glycosidase, hydrolase; 1.50A {Gallus gallus} SCOP: d.2.1.2 PDB: 3b6l_A 1lsy_A 1lsz_A* | Back alignment and structure |
|---|
| >1lsg_A Hen egg white lysozyme; fibrinogen, hybrid protein; 2.40A {Gallus gallus} SCOP: d.2.1.2 | Back alignment and structure |
|---|
| >2vb1_A Lysozyme C; antimicrobial, triclinic HEWL, atomic resolution, allergen, hydrolase, glycosidase, bacteriolytic enzyme; HET: EDO; 0.65A {Gallus gallus} SCOP: d.2.1.2 PDB: 194l_A 1aki_A 1azf_A 1b0d_A* 1b2k_A 1bgi_A 1bhz_A 1bvk_C 1bvx_A 1bwh_A 1bwi_A 1bwj_A 1c08_C 1c10_A 1dpw_A 1dpx_A 1dqj_C 1e8l_A 1f0w_A 1f10_A ... | Back alignment and structure |
|---|
| >1jug_A Lysozyme; calcium-binding; 1.90A {Tachyglossus aculeatus} SCOP: d.2.1.2 | Back alignment and structure |
|---|
| >1lmq_A Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1.60A {Oncorhynchus mykiss} SCOP: d.2.1.2 PDB: 1bb7_A* 1lmc_A* 1bb6_A 1lmo_A* 1lmp_A* 1lmn_A* | Back alignment and structure |
|---|
| >1iiz_A Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCOP: d.2.1.2 PDB: 1gd6_A | Back alignment and structure |
|---|
| >1qqy_A Lysozyme C; APO-type protein, calcium binding lysozyme, enzyme, hydrolase; 1.85A {Canis lupus familiaris} SCOP: d.2.1.2 PDB: 1el1_A 1i56_A 2cwi_A 2z2e_A 2eql_A | Back alignment and structure |
|---|
| >2goi_A Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1, sperm C-type lysozyme-like protein 1, acrosomal sperm protein, sperm-egg binding, fertilization; 2.30A {Mus musculus} | Back alignment and structure |
|---|
| >2gv0_A Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} | Back alignment and structure |
|---|
| >2nwd_X Lysozyme C; native chemical ligation, chemical protein synthesis, convergent synthesis, hydrolase; 1.04A {Synthetic} SCOP: d.2.1.2 PDB: 1iwu_A 1iwv_A 1iww_A 1iwx_A 1iwy_A 1iwz_A 1iy3_A 1iy4_A 1iwt_A 1jwr_A 1lz1_A 1lzr_A* 1lzs_A* 1op9_B 1re2_A* 1rem_A* 1rex_A 1rey_A* 1rez_A* 1jsf_A ... | Back alignment and structure |
|---|
| >1b9o_A Protein (alpha-lactalbumin); calcium-binding protein, high resolution; 1.15A {Homo sapiens} SCOP: d.2.1.2 PDB: 1a4v_A 1alc_A 1hmk_A 1hfy_A 1f6r_A 1f6s_A 2g4n_A 1fkq_A 1fkv_A 1hfz_A 1hfx_A | Back alignment and structure |
|---|
| >2vb1_A Lysozyme C; antimicrobial, triclinic HEWL, atomic resolution, allergen, hydrolase, glycosidase, bacteriolytic enzyme; HET: EDO; 0.65A {Gallus gallus} SCOP: d.2.1.2 PDB: 194l_A 1aki_A 1azf_A 1b0d_A* 1b2k_A 1bgi_A 1bhz_A 1bvk_C 1bvx_A 1bwh_A 1bwi_A 1bwj_A 1c08_C 1c10_A 1dpw_A 1dpx_A 1dqj_C 1e8l_A 1f0w_A 1f10_A ... | Back alignment and structure |
|---|
| >1yro_A Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL complex, transferase activator/transferase complex; HET: GDU UDP MES PG4; 1.90A {Mus musculus} SCOP: d.2.1.2 PDB: 1nhe_A* 1nkh_A* 1nmm_A* 1nqi_A* 1nwg_A* 1o23_A* 1oqm_A* 1pzy_A* 1nf5_A* 2fyc_A* 2fyd_A* | Back alignment and structure |
|---|
| >2z2f_A Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylmuramidase C, bacteriolytic enzyme, hydrolase; 1.50A {Bos taurus} | Back alignment and structure |
|---|
| >1hml_A Alpha-lactalbumin; calcium-binding protein; 1.70A {Homo sapiens} SCOP: d.2.1.2 | Back alignment and structure |
|---|
| >1lsg_A Hen egg white lysozyme; fibrinogen, hybrid protein; 2.40A {Gallus gallus} SCOP: d.2.1.2 | Back alignment and structure |
|---|
| >2fbd_A Lysozyme 1; digestive lysozime, hydrolase; HET: PEG; 1.90A {Musca domestica} PDB: 2h5z_A* 3cb7_A | Back alignment and structure |
|---|
| >3b72_A Lysozyme C; hen egg-white lysozyme, protein-SDS complex, MPD, allergen, antimicrobial, bacteriolytic enzyme glycosidase, hydrolase; 1.50A {Gallus gallus} SCOP: d.2.1.2 PDB: 3b6l_A 1lsy_A 1lsz_A* | Back alignment and structure |
|---|
| >1lmq_A Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1.60A {Oncorhynchus mykiss} SCOP: d.2.1.2 PDB: 1bb7_A* 1lmc_A* 1bb6_A 1lmo_A* 1lmp_A* 1lmn_A* | Back alignment and structure |
|---|
| >1jug_A Lysozyme; calcium-binding; 1.90A {Tachyglossus aculeatus} SCOP: d.2.1.2 | Back alignment and structure |
|---|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
| >4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
| >4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* | Back alignment and structure |
|---|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* | Back alignment and structure |
|---|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
| >1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A | Back alignment and structure |
|---|
| >2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A | Back alignment and structure |
|---|
| >3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} | Back alignment and structure |
|---|
| >1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A | Back alignment and structure |
|---|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
| >1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A | Back alignment and structure |
|---|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
| >3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A | Back alignment and structure |
|---|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
| >2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A | Back alignment and structure |
|---|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A | Back alignment and structure |
|---|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
| >1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... | Back alignment and structure |
|---|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A | Back alignment and structure |
|---|
| >3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... | Back alignment and structure |
|---|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... | Back alignment and structure |
|---|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A | Back alignment and structure |
|---|
| >1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* | Back alignment and structure |
|---|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... | Back alignment and structure |
|---|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
| >1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A | Back alignment and structure |
|---|
| >3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A | Back alignment and structure |
|---|
| >2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A | Back alignment and structure |
|---|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* | Back alignment and structure |
|---|
| >1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* | Back alignment and structure |
|---|
| >3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A | Back alignment and structure |
|---|
| >1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A | Back alignment and structure |
|---|
| >2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A | Back alignment and structure |
|---|
| >1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >3asi_A Neurexin-1-alpha; beta-sandwich, cell adhesion, synapse maturation, neuroligin glycosylation, membrane; HET: NAG; 2.30A {Bos taurus} | Back alignment and structure |
|---|
| >2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* | Back alignment and structure |
|---|
| >1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* | Back alignment and structure |
|---|
| >1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A | Back alignment and structure |
|---|
| >2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* | Back alignment and structure |
|---|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* | Back alignment and structure |
|---|
| >2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
| >3asi_A Neurexin-1-alpha; beta-sandwich, cell adhesion, synapse maturation, neuroligin glycosylation, membrane; HET: NAG; 2.30A {Bos taurus} | Back alignment and structure |
|---|
| >1gbs_A Australian black SWAN egg white lysozyme; hydrolase (O-glycosyl); 1.50A {Cygnus atratus} SCOP: d.2.1.5 PDB: 1lsp_A* 153l_A 154l_A* | Back alignment and structure |
|---|
| >2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* | Back alignment and structure |
|---|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A | Back alignment and structure |
|---|
| >3qcw_A Neurexin-1-alpha; synaptic adhesion molecule, cell adhesion; HET: NAG; 2.65A {Bos taurus} PDB: 3r05_A* 3poy_A* | Back alignment and structure |
|---|
| >3gxr_A Goose-type lysozyme 1; atlantic COD, FISH lysozyme, active site residues, substrate sites, surface potential, muramidase activity; HET: NAG; 1.70A {Gadus morhua} SCOP: d.2.1.5 PDB: 3gxk_A* | Back alignment and structure |
|---|
| >3qcw_A Neurexin-1-alpha; synaptic adhesion molecule, cell adhesion; HET: NAG; 2.65A {Bos taurus} PDB: 3r05_A* 3poy_A* | Back alignment and structure |
|---|
| >2e26_A Reelin, reeler protein; signaling protein; HET: NAG BMA; 2.00A {Mus musculus} PDB: 3a7q_A* | Back alignment and structure |
|---|
| >2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* | Back alignment and structure |
|---|
| >1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
| >4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus} | Back alignment and structure |
|---|
| >2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* | Back alignment and structure |
|---|
| >1nzi_A Complement C1S component; calcium, innate immunity, modular structure, CUB, EGF, hydrolase; 1.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 769 | ||||
| d1qqya_ | 130 | d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), mil | 5e-33 | |
| d1qqya_ | 130 | d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), mil | 3e-18 | |
| d1gd6a_ | 119 | d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [Tax | 3e-32 | |
| d1gd6a_ | 119 | d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [Tax | 9e-19 | |
| d2nwdx1 | 130 | d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [ | 7e-32 | |
| d2nwdx1 | 130 | d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [ | 4e-17 | |
| d1yroa1 | 123 | d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus mu | 3e-31 | |
| d1yroa1 | 123 | d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus mu | 5e-17 | |
| d1b9oa_ | 123 | d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapien | 3e-31 | |
| d1b9oa_ | 123 | d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapien | 1e-16 | |
| d1hfxa_ | 123 | d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia | 5e-31 | |
| d1hfxa_ | 123 | d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia | 1e-16 | |
| d2vb1a1 | 129 | d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus | 4e-29 | |
| d2vb1a1 | 129 | d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus | 1e-17 | |
| d1lmqa_ | 129 | d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus | 6e-29 | |
| d1lmqa_ | 129 | d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus | 1e-16 | |
| d1juga_ | 125 | d.2.1.2 (A:) Lysozyme {Australian echidna (Tachygl | 2e-28 | |
| d1juga_ | 125 | d.2.1.2 (A:) Lysozyme {Australian echidna (Tachygl | 3e-17 | |
| d1tpga1 | 41 | g.3.11.1 (A:51-91) Plasminogen activator (tissue-t | 2e-05 | |
| d3egfa_ | 53 | g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse | 3e-05 | |
| d3egfa_ | 53 | g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse | 0.002 | |
| d1edmb_ | 39 | g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens | 7e-05 | |
| d1edmb_ | 39 | g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens | 1e-04 | |
| d2c4fl1 | 37 | g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrof | 1e-04 | |
| d2c4fl1 | 37 | g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrof | 2e-04 | |
| d1xkba1 | 39 | g.3.11.1 (A:48-86) Factor X, N-terminal module {Hu | 1e-04 | |
| d1xkba1 | 39 | g.3.11.1 (A:48-86) Factor X, N-terminal module {Hu | 2e-04 | |
| d2vj3a1 | 42 | g.3.11.1 (A:411-452) Neurogenic locus notch homolo | 1e-04 | |
| d2vj3a1 | 42 | g.3.11.1 (A:411-452) Neurogenic locus notch homolo | 0.003 | |
| d1nqlb_ | 48 | g.3.11.1 (B:) Epidermal growth factor, EGF {Human | 2e-04 | |
| d2vj3a2 | 39 | g.3.11.1 (A:453-491) Neurogenic locus notch homolo | 2e-04 | |
| d2vj3a2 | 39 | g.3.11.1 (A:453-491) Neurogenic locus notch homolo | 2e-04 | |
| d2vj3a3 | 35 | g.3.11.1 (A:492-526) Neurogenic locus notch homolo | 2e-04 | |
| d2vj3a3 | 35 | g.3.11.1 (A:492-526) Neurogenic locus notch homolo | 3e-04 | |
| d1g1sa2 | 40 | g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human | 4e-04 | |
| d1g1sa2 | 40 | g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human | 0.002 | |
| d1g1ta2 | 39 | g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human | 7e-04 | |
| d1g1ta2 | 39 | g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human | 0.002 | |
| d1cvua2 | 41 | g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EG | 0.001 | |
| d1q4ga2 | 42 | g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EG | 0.002 |
| >d1qqya_ d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), milk [TaxId: 9615]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Lysozyme-like superfamily: Lysozyme-like family: C-type lysozyme domain: Lysozyme species: Dog (Canis familiaris), milk [TaxId: 9615]
Score = 121 bits (305), Expect = 5e-33
Identities = 47/129 (36%), Positives = 67/129 (51%), Gaps = 10/129 (7%)
Query: 279 KRFGACELAKFLVRQR--GIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQIN 336
K F CELA+ L G + WVC+A ESN N+ A + +N NGS D+GIFQ+N
Sbjct: 2 KIFSKCELARKLKSMGMDGFHGYSLANWVCMAEYESNFNTQAFNGRNSNGSSDYGIFQLN 61
Query: 337 DKYWCTASGP-AGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTY-HYC 394
K+WC ++ + C+ CS F D+NI DD+AC ++ G AW + +C
Sbjct: 62 SKWWCKSNSHSSANACNIMCSKFLDDNIDDDIACAKRVVKDPN-----GMSAWVAWVKHC 116
Query: 395 NTNSKVSTY 403
+S Y
Sbjct: 117 K-GKDLSKY 124
|
| >d1qqya_ d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), milk [TaxId: 9615]} Length = 130 | Back information, alignment and structure |
|---|
| >d1gd6a_ d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} Length = 119 | Back information, alignment and structure |
|---|
| >d1gd6a_ d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} Length = 119 | Back information, alignment and structure |
|---|
| >d2nwdx1 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
| >d2nwdx1 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
| >d1yroa1 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10090]} Length = 123 | Back information, alignment and structure |
|---|
| >d1yroa1 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10090]} Length = 123 | Back information, alignment and structure |
|---|
| >d1b9oa_ d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 9606]} Length = 123 | Back information, alignment and structure |
|---|
| >d1b9oa_ d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 9606]} Length = 123 | Back information, alignment and structure |
|---|
| >d1hfxa_ d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia porcellus) [TaxId: 10141]} Length = 123 | Back information, alignment and structure |
|---|
| >d1hfxa_ d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia porcellus) [TaxId: 10141]} Length = 123 | Back information, alignment and structure |
|---|
| >d2vb1a1 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} Length = 129 | Back information, alignment and structure |
|---|
| >d2vb1a1 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} Length = 129 | Back information, alignment and structure |
|---|
| >d1lmqa_ d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]} Length = 129 | Back information, alignment and structure |
|---|
| >d1lmqa_ d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]} Length = 129 | Back information, alignment and structure |
|---|
| >d1juga_ d.2.1.2 (A:) Lysozyme {Australian echidna (Tachyglossus aculeatus) [TaxId: 9261]} Length = 125 | Back information, alignment and structure |
|---|
| >d1juga_ d.2.1.2 (A:) Lysozyme {Australian echidna (Tachyglossus aculeatus) [TaxId: 9261]} Length = 125 | Back information, alignment and structure |
|---|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} Length = 41 | Back information, alignment and structure |
|---|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} Length = 53 | Back information, alignment and structure |
|---|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} Length = 53 | Back information, alignment and structure |
|---|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Length = 37 | Back information, alignment and structure |
|---|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Length = 37 | Back information, alignment and structure |
|---|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} Length = 48 | Back information, alignment and structure |
|---|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 35 | Back information, alignment and structure |
|---|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 35 | Back information, alignment and structure |
|---|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Length = 40 | Back information, alignment and structure |
|---|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Length = 40 | Back information, alignment and structure |
|---|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} Length = 41 | Back information, alignment and structure |
|---|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} Length = 42 | Back information, alignment and structure |
|---|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 769 | |||
| d1lmqa_ | 129 | Lysozyme {Rainbow trout (Oncorhynchus mykiss) [Tax | 100.0 | |
| d1juga_ | 125 | Lysozyme {Australian echidna (Tachyglossus aculeat | 100.0 | |
| d2vb1a1 | 129 | Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} | 100.0 | |
| d1qqya_ | 130 | Lysozyme {Dog (Canis familiaris), milk [TaxId: 961 | 100.0 | |
| d1b9oa_ | 123 | alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 96 | 100.0 | |
| d2nwdx1 | 130 | Lysozyme {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gd6a_ | 119 | Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} | 100.0 | |
| d1hfxa_ | 123 | alpha-Lactalbumin {Guinea pig (Cavia porcellus) [T | 100.0 | |
| d1yroa1 | 123 | alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10 | 100.0 | |
| d2vb1a1 | 129 | Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} | 99.96 | |
| d1lmqa_ | 129 | Lysozyme {Rainbow trout (Oncorhynchus mykiss) [Tax | 99.96 | |
| d1juga_ | 125 | Lysozyme {Australian echidna (Tachyglossus aculeat | 99.95 | |
| d1qqya_ | 130 | Lysozyme {Dog (Canis familiaris), milk [TaxId: 961 | 99.95 | |
| d2nwdx1 | 130 | Lysozyme {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1b9oa_ | 123 | alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 96 | 99.94 | |
| d1gd6a_ | 119 | Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} | 99.94 | |
| d1hfxa_ | 123 | alpha-Lactalbumin {Guinea pig (Cavia porcellus) [T | 99.93 | |
| d1yroa1 | 123 | alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10 | 99.93 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 98.59 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 98.56 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.55 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.48 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.46 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.43 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 98.42 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.42 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 98.41 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 98.4 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 98.37 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 98.31 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 98.26 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.25 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 98.17 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 98.15 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 98.08 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 98.01 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.98 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 97.97 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 97.92 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 97.91 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.83 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 97.75 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 97.66 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 97.62 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 97.62 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 97.61 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 97.6 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.52 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 97.52 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.41 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 97.38 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 97.26 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.15 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 97.06 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.03 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.98 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.92 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.91 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 96.85 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 96.83 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.82 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 96.75 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.66 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 96.49 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 96.39 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 96.27 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 96.27 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 96.13 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 95.82 | |
| d1ioxa_ | 50 | Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] | 95.81 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 95.67 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 95.63 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 95.63 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 95.59 | |
| d1moxc_ | 49 | Transforming growth factor alpha {Human (Homo sapi | 95.03 | |
| d1ioxa_ | 50 | Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] | 94.82 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 94.8 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 94.78 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.25 | |
| d1moxc_ | 49 | Transforming growth factor alpha {Human (Homo sapi | 94.24 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 94.08 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.98 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 93.83 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 92.6 | |
| d1xdtr_ | 41 | Heparin-binding epidermal growth factor, HBEGF {Hu | 91.4 | |
| d1xsfa1 | 86 | Probable resuscitation-promoting factor RpfB {Myco | 91.23 | |
| d1gbsa_ | 185 | Lysozyme {Australian black swan (Cygnus atratus) [ | 90.15 | |
| d1kloa1 | 55 | Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: | 89.62 | |
| d1autl2 | 50 | Activated protein c (autoprothrombin IIa) {Human ( | 85.65 | |
| d1xdtr_ | 41 | Heparin-binding epidermal growth factor, HBEGF {Hu | 85.27 | |
| d1autl2 | 50 | Activated protein c (autoprothrombin IIa) {Human ( | 85.21 | |
| d2p3ua1 | 51 | Factor X, N-terminal module {Human (Homo sapiens) | 83.98 | |
| d1kigl_ | 51 | Factor X, N-terminal module {Cow (Bos taurus) [Tax | 83.84 | |
| d2p3ua1 | 51 | Factor X, N-terminal module {Human (Homo sapiens) | 81.81 | |
| d1qsaa2 | 168 | 70 kDa soluble lytic transglycosylase, SLT70 {Esch | 81.44 |
| >d1lmqa_ d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Lysozyme-like superfamily: Lysozyme-like family: C-type lysozyme domain: Lysozyme species: Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]
Probab=100.00 E-value=4.8e-49 Score=365.14 Aligned_cols=124 Identities=32% Similarity=0.710 Sum_probs=115.0
Q ss_pred eeecchHHHHHHHHh--cCCCCCCcccceEeeccccCCCcccccCCCCCCCceeeeeeeccccccCCCCCC--ccccccc
Q psy9686 279 KRFGACELAKFLVRQ--RGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPA--GKECHAK 354 (769)
Q Consensus 279 k~~~rCela~~l~~~--~g~~~~~l~~wvCla~~eS~~~t~a~~~~~~~gs~~yGifQIn~~~WC~~~~~~--~~~C~~~ 354 (769)
|||+|||||++|++. +|||+++|++|||||+|||+|||+|+++ |.|||+||||||||++|||++++++ +|.|+|+
T Consensus 1 Ki~~rCeLAr~L~~~gl~gf~~~~l~~WvCla~~ES~~nT~a~~~-n~~gS~dyGiFQIn~~~WC~~~~~~~~~N~C~i~ 79 (129)
T d1lmqa_ 1 KVYDRCELARALKASGMDGYAGNSLPNWVCLSKWESSYNTQATNR-NTDGSTDYGIFQINSRYWCDDGRTPGAKNVCGIR 79 (129)
T ss_dssp CBCCHHHHHHHHHHTTCTTBTTBCHHHHHHHHHHHHTTBTTCEEE-CTTSCEEETTTTEETTTSCBCSCCTTCCCTTCSB
T ss_pred CcccHhHHHHHHHHcCCcCCChhhHHHHHHHHHHhccCccccccc-CCCCCCCcceeeecchhcccCCCCCCCCCCCCCc
Confidence 799999999999985 3579999999999999999999999997 6799999999999999999987654 6899999
Q ss_pred cccccCCChhHHHHHHHHHHhcccccccCcccccccCc-cccCCCCCccccccCCc
Q psy9686 355 CSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YCNTNSKVSTYDHADDM 409 (769)
Q Consensus 355 C~~ll~~di~~~i~Cak~i~~~~~~~~~~G~~aW~~w~-~C~g~~~l~~~~~~~~~ 409 (769)
|++||||||+|||+|||+|+.++ +||+||++|+ +|+|+ +|+.|...|++
T Consensus 80 C~~Ll~ddI~ddi~CAkkIv~~~-----~G~~AW~~w~~~C~g~-~L~~~i~~C~l 129 (129)
T d1lmqa_ 80 CSQLLTDDLTVAIRCAKRVVLDP-----NGIGAWVAWRLHCQNQ-DLRSYVAGCGV 129 (129)
T ss_dssp GGGGSSSSCHHHHHHHHHHTTST-----TGGGGCHHHHHHTTTS-CCGGGTTTSCC
T ss_pred HHHHcCCCcHHHHHHHHHHHhcc-----cCcchhHHHHHHcCCC-ChHHHHhcCCC
Confidence 99999999999999999999886 8999999999 99996 99999887764
|
| >d1juga_ d.2.1.2 (A:) Lysozyme {Australian echidna (Tachyglossus aculeatus) [TaxId: 9261]} | Back information, alignment and structure |
|---|
| >d2vb1a1 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
| >d1qqya_ d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), milk [TaxId: 9615]} | Back information, alignment and structure |
|---|
| >d1b9oa_ d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2nwdx1 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gd6a_ d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} | Back information, alignment and structure |
|---|
| >d1hfxa_ d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia porcellus) [TaxId: 10141]} | Back information, alignment and structure |
|---|
| >d1yroa1 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d2vb1a1 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
| >d1lmqa_ d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]} | Back information, alignment and structure |
|---|
| >d1juga_ d.2.1.2 (A:) Lysozyme {Australian echidna (Tachyglossus aculeatus) [TaxId: 9261]} | Back information, alignment and structure |
|---|
| >d1qqya_ d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), milk [TaxId: 9615]} | Back information, alignment and structure |
|---|
| >d2nwdx1 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1b9oa_ d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gd6a_ d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} | Back information, alignment and structure |
|---|
| >d1hfxa_ d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia porcellus) [TaxId: 10141]} | Back information, alignment and structure |
|---|
| >d1yroa1 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
| >d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xsfa1 d.2.1.8 (A:23-108) Probable resuscitation-promoting factor RpfB {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
| >d1gbsa_ d.2.1.5 (A:) Lysozyme {Australian black swan (Cygnus atratus) [TaxId: 8868]} | Back information, alignment and structure |
|---|
| >d1kloa1 g.3.11.2 (A:11-65) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1qsaa2 d.2.1.6 (A:451-618) 70 kDa soluble lytic transglycosylase, SLT70 {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|